Virginia National Bankshares (VABK) 10-Q 11 Aug 23 2023 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2023	Aug. 10, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2023
Entity Registrant Name	VIRGINIA NATIONAL BANKSHARES CORP
Entity Central Index Key	0001572334
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		5,365,982
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity File Number	001-40305
Entity Incorporation, State or Country Code	VA
Entity Tax Identification Number	46-2331578
Entity Address, Address Line One	404 People Place
Entity Address, City or Town	Charlottesville
Entity Address, State or Province	VA
Entity Address, Postal Zip Code	22911
City Area Code	434
Local Phone Number	817-8621
Entity Shell Company	false
Document Quarterly Report	true
Document Transition Report	false
Title of 12(b) Security	Common Stock
Trading Symbol	VABK
Security Exchange Name	NASDAQ

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Jun. 30, 2023	Dec. 31, 2022
ASSETS
Cash and due from banks		$ 9,714	$ 20,993	[1]
Interest-bearing deposits in other banks		20,225	19,098	[1]
Federal funds sold	[1]		45
Securities:
Available for sale, at fair value		473,868	538,186	[1]
Restricted securities, at cost		7,438	5,137	[1]
Total securities		481,306	543,323	[1]
Loans, net of deferred fees and costs		973,348	936,415	[1]
Allowance for credit losses		(7,863)	(5,552)	[1]
Loans, net		965,485	930,863	[1]
Premises and equipment, net		17,564	17,808	[1]
Assets held for sale	[1]		965
Bank owned life insurance		39,065	38,552	[1]
Goodwill		7,768	7,768	[1]
Right of use asset, net		6,634	6,536	[1]
Deferred tax asset, net		16,961	17,315	[1]
Accrued interest receivable and other assets		13,551	13,507	[1]
Total assets		1,584,088	1,623,359	[1]
Demand deposits:
Noninterest-bearing		412,273	495,649	[1]
Interest-bearing		312,773	399,983	[1]
Money market and savings deposit accounts		398,074	467,600	[1]
Certificates of deposit and other time deposits		224,956	115,106	[1]
Total deposits		1,348,076	1,478,338	[1]
Federal funds purchased		20,503
Short-term borrowings		59,666
Junior subordinated debt, net		3,436	3,413	[1]
Lease liability		6,301	6,173	[1]
Accrued interest payable and other liabilities		3,667	2,019	[1]
Total liabilities		1,441,649	1,489,943	[1]
Commitments and contingent liabilities
Shareholders' equity:
Preferred stock, $2.50 par value				[1]
Common stock, $2.50 par value		13,250	13,214	[1]
Capital surplus		105,667	105,344	[1]
Retained earnings		69,502	63,482	[1]
Accumulated other comprehensive loss		(45,980)	(48,624)	[1]
Total shareholders' equity		142,439	133,416	[1]
Total liabilities and shareholders' equity		$ 1,584,088	$ 1,623,359	[1]
Common stock, shares outstanding		5,365,982	5,337,271	[1]
Common stock, shares authorized		10,000,000	10,000,000	[1]
Preferred stock, shares outstanding		0	0	[1]
Preferred stock, shares authorized		2,000,000	2,000,000	[1]
Core Deposit [Member]
Securities:
Intangible assets, net		$ 5,815	$ 6,586	[1]
[1] Derived from audited Consolidated Financial Statements

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Preferred stock, par value per share	$ 2.5	$ 2.5
Common stock, par value per share	$ 2.5	$ 2.5

CONSOLIDATED STATEMENTS OF INCO

CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Interest and dividend income:
Loans, including fees	$ 14,894	$ 10,610	$ 27,661	$ 21,379
Federal funds sold	10	302	10	363
Other interest-bearing deposits	119	219	378	355
Investment securities:
Taxable	2,876	1,662	5,826	2,674
Tax exempt	329	308	656	612
Dividends	104	64	171	126
Total interest and dividend income	18,332	13,165	34,702	25,509
Interest expense:
Demand deposits	106	58	195	119
Money market and savings deposits	2,197	440	3,970	1,055
Certificates and other time deposits	1,776	157	2,424	352
Federal funds purchased	32		91
Short-term borrowings	439		766
Junior subordinated debt	79	49	140	97
Total interest expense	4,629	704	7,586	1,623
Net interest income	13,703	12,461	27,116	23,886
Provision for (recovery of) credit losses	261	(217)	13	(69)
Net interest income after provision for (recovery of) credit losses	13,442	12,678	27,103	23,955
Noninterest income:
Wealth management fees	397	572	801	1,129
Advisory and brokerage income		210		426
Deposit account fees	399	458	800	923
Debit/credit card and ATM fees	636	779	1,207	1,486
Bank owned life insurance income	261	246	513	457
Resolution of commercial dispute				2,400
Gains on sale of assets		1,113		1,113
Gain on termination of interest swap			460
Loss on sales of AFS, net			(206)
Other	352	268	746	499
Total noninterest income	2,045	3,646	4,321	8,433
Noninterest expense:
Salaries and employee benefits	4,062	4,086	8,113	8,817
Net occupancy	929	1,282	2,108	2,479
Equipment	176	254	394	537
Bank franchise tax	313	304	637	608
Computer software	203	357	405	620
Data processing	806	699	1,548	1,437
FDIC deposit insurance assessment	220	125	320	351
Marketing, advertising and promotion	275	259	650	526
Plastics Expense	30	92	78	231
Professional fees	198	404	390	741
Core deposit intangible amortization	379	427	770	866
Other	973	1,153	2,012	2,324
Total noninterest expense	8,564	9,442	17,425	19,537
Income before income taxes	6,923	6,882	13,999	12,851
Provision for income taxes	1,272	1,197	2,557	2,242
Net income	$ 5,651	$ 5,685	$ 11,442	$ 10,609
Net income per common share, basic	$ 1.05	$ 1.07	$ 2.14	$ 1.99
Net income per common share, diluted	$ 1.05	$ 1.06	$ 2.13	$ 1.98
Weighted average common shares outstanding, basic	5,357,873	5,326,271	5,348,040	5,319,166
Weighted average common shares outstanding, diluted	5,375,073	5,347,008	5,375,545	5,345,242

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 5,651	$ 5,685	$ 11,442	$ 10,609
Other comprehensive income (loss):
Unrealized losses on securities, net of tax of ($831) and $766 for the three and six months ended June 30, 2023; and net of tax benefit of ($4,308) and ($9,536) for the three and six months ended June 30, 2022; respectively	(3,127)	(16,214)	2,881	(35,879)
Reclassification adjustment for realized gain on termination of interest rate swap, net of tax benefit of $0 and ($97) for the three and six months ended June 30, 2023; respectively			(363)
Reclassification adjustment for realized losses on securities, net of tax of $0 and $43 for the three and six months ended June 30, 2023, respectively			163
Unrealized gains (losses) on interest rate swaps, net of tax benefit of $0 and ($9) for the three and six months ended June 30, 2023; and net of tax of $42 and $104 for the three and six months ended June 30, 2022; respectively		160	(37)	395
Total other comprehensive income (loss)	(3,127)	(16,054)	2,644	(35,484)
Total comprehensive income (loss)	$ 2,524	$ (10,369)	$ 14,086	$ (24,875)

CONSOLIDATED STATEMENTS OF CO_2

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Statement of Comprehensive Income [Abstract]
Change in unrealized losses on available-for-sale securities, tax	$ 831	$ 4,308	$ 766	$ 9,536
Reclassification adjustment for realized gain on termination of interest rate swap, tax	0		97
Reclassification adjustment for realized losses on securities, tax	0		43
Unrealized gains (losses) on interest rate swaps, tax	$ 0	$ 42	$ 9	$ 104

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total		Common Stock [Member]	Capital Surplus [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Loss [Member]
Balance at Dec. 31, 2021	$ 161,987		$ 13,178	$ 104,584	$ 46,436	$ (2,211)
Stock option expense	41			41
Restricted stock grant expense	93			93
Vested stock grants			12	(12)
Cash dividends declared	(1,596)				(1,596)
Net income	4,924				4,924
Other comprehensive income (loss)	(19,430)					(19,430)
Balance at Mar. 31, 2022	146,019		13,190	104,706	49,764	(21,641)
Balance at Dec. 31, 2021	161,987		13,178	104,584	46,436	(2,211)
Net income	10,609
Balance at Jun. 30, 2022	134,216		13,201	104,858	53,852	(37,695)
Balance at Mar. 31, 2022	146,019		13,190	104,706	49,764	(21,641)
Stock option expense	42			42
Restricted stock grant expense	121			121
Vested stock grants			11	(11)
Cash dividends declared	(1,597)				(1,597)
Net income	5,685				5,685
Other comprehensive income (loss)	(16,054)					(16,054)
Balance at Jun. 30, 2022	134,216		13,201	104,858	53,852	(37,695)
Balance at Dec. 31, 2022	133,416	[1]	13,214	105,344	63,482	(48,624)
Exercise of stock options	18		3	15
Stock option expense	42			42
Restricted stock grant expense	111			111
Vested restricted stock grants			21	(21)
Cash dividends declared	(1,762)				(1,762)
Impact of adoption of CECL	(1,890)				(1,890)
Net income	5,791				5,791
Other comprehensive income (loss)	5,771					5,771
Balance at Mar. 31, 2023	141,497		13,238	105,491	65,621	(42,853)
Balance at Dec. 31, 2022	133,416	[1]	13,214	105,344	63,482	(48,624)
Net income	11,442
Balance at Jun. 30, 2023	142,439		13,250	105,667	69,502	(45,980)
Balance at Mar. 31, 2023	141,497		13,238	105,491	65,621	(42,853)
Stock option expense	68			68
Restricted stock grant expense	120			120
Vested stock grants			12	(12)
Cash dividends declared	(1,770)				(1,770)
Net income	5,651				5,651
Other comprehensive income (loss)	(3,127)					(3,127)
Balance at Jun. 30, 2023	$ 142,439		$ 13,250	$ 105,667	$ 69,502	$ (45,980)
[1] Derived from audited Consolidated Financial Statements

CONSOLIDATED STATEMENTS OF CH_2

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) (Unaudited) - $ / shares	3 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022
Statement of Stockholders' Equity [Abstract]
Cash dividend declared, per share	$ 0.33	$ 0.33	$ 0.3	$ 0.3

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 11,442	$ 10,609
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for (recovery of) credit losses	13	(69)
Net accretion of certain acquisition-related adjustments	(4,671)	(1,023)
Amortization of intangible assets	770	900
Net amortization and (accretion) of securities	(1,117)	539
Net losses on sale of AFS	206
Net gains on sale of other assets		(1,113)
Earnings on bank owned life insurance	(513)	(457)
Depreciation and other amortization	1,654	1,921
Stock option expense	110	83
Stock grant expense	231	214
Net change in:
Accrued interest receivable and other assets	344	94
Accrued interest payable and other liabilities	1,648	(2,032)
Net cash provided by operating activities	10,117	9,666
CASH FLOWS FROM INVESTING ACTIVITIES:
Net increase in restricted investments	(2,301)	(188)
Purchases of available for sale securities	(10,000)	(216,525)
Proceeds from maturities, calls, sales and principal payments of available for sale securities	78,930	12,558
Net change in loans	(34,282)	101,621
Purchase of bank owned life insurance		(6,355)
Proceeds from sale of premises and equipment	962	6,207
Proceeds from sale of other real estate owned		610
Purchase of bank premises and equipment	(501)	(334)
Net cash provided by (used in) investing activities	32,808	(102,406)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net change in demand deposits, interest checking, money market and savings accounts	(240,112)	(185,348)
Net change in certificates of deposit and other time deposits	109,856	(11,892)
Net change in federal funds purchased	20,503
Net change in other borrowings	59,666
Proceed from termination of interest swap	479
Proceeds from stock options exercised	18
Cash dividends paid	(3,532)	(3,193)
Net cash used in financing activities	(53,122)	(200,433)
NET DECREASE IN CASH AND CASH EQUIVALENTS	(10,197)	(293,173)
CASH AND CASH EQUIVALENTS:
Beginning of period	40,136	508,840
End of period	29,939	215,667
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest	2,705	1,664
Taxes	2,134	1,500
SUPPLEMENTAL SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES
Unrealized losses on available for sale securities	$ 3,852	(45,415)
Unrealized gains on interest rate swaps		499
Initial right-of-use assets obtained in exchange for new operating lease liabilities		$ 540

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 1. Summary of Significant Accounting Policies Principles of Consolidation: The unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information. Accordingly, the unaudited consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. The statements should be read in conjunction with the Notes to Consolidated Financial Statements included in the Company’s Form 10-K for the year ended December 31, 2022 . Nature of Operations: The accompanying unaudited consolidated financial statements include the accounts of the Company, and its subsidiaries Virginia National Bank and Masonry Capital Management, LLC, a registered investment advisor. The Bank offers a full range of banking and related financial services to meet the needs of individuals, businesses and charitable organizations, including the fiduciary services of VNB Trust and Estate Services. Until the sale of the business line on December 19, 2022, the Bank also offered, through networking agreements with third parties, investment advisory and other investment services under Sturman Wealth Advisors. All significant intercompany balances and transactions have been eliminated in consolidation. Basis of Presentation: The preparation of financial statements in conformity with GAAP and the reporting guidelines prescribed by regulatory authorities requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the determination of the ACL, accounting for business combinations, including loans acquired in the business combination, ACL on individually evaluated loans, goodwill impairment, credit losses of securities, other intangible assets, and fair value measurements. Operating results for the three and six months ended June 30, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023 . Reclassifications: If needed, certain previously reported amounts have been reclassified to conform to current period presentation. No such reclassifications were significant. Recent Significant Accounting Pronouncements Financial Statement Presentation - In July 2023, the FASB issued ASU 2023-03, “Presentation of Financial Statements (Topic 205), Income Statement—Reporting Comprehensive Income (Topic 220), Distinguishing Liabilities from Equity (Topic 480), Equity (Topic 505), and Compensation—Stock Compensation (Topic 718)”. This ASU amends the FASB Accounting Standards Codification for SEC paragraphs pursuant to SEC Staff Accounting Bulletin No. 120, SEC Staff Announcement at the March 24, 2022 Emerging Issues Task Force Meeting, and Staff Accounting Bulletin Topic 6.B, Accounting Series Release 280—General Revision of Regulation S-X: Income or Loss Applicable to Common Stock. ASU 2023-03 is effective upon addition to the FASB Codification. The Company does not expect the adoption of ASU 2023-03 to have a material impact on its consolidated financial statements. Investments in Tax Credit Structures - In March 2023, the FASB issued ASU 2023-02, “Investments—Equity Method and Joint Ventures (Topic 323): Accounting for Investments in Tax Credit Structures Using the Proportional Amortization Method”. These amendments allow reporting entities to elect to account for qualifying tax equity investments using the proportional amortization method, regardless of the program giving rise to the related income tax credits. The ASU is effective for public business entities for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted for all entities in any interim period. The Company does not expect the adoption of ASU 2023-02 to have a material impact on its consolidated financial statements. LIBOR and Other Reference Rates - In December 2022, the FASB issued ASU 2022-06, “Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848”. ASU 2022-06 extends the period of time preparers can utilize the reference rate reform relief guidance in Topic 848. The objective of the guidance in Topic 848 is to provide relief during the temporary transition period, so the FASB included a sunset provision within Topic 848 based on expectations of when the LIBOR would cease being published. In 2021, the UK Financial Conduct Authority (FCA) delayed the intended cessation date of certain tenors of USD LIBOR to June 30, 2023. To ensure the relief in Topic 848 covers the period of time during which a significant number of modifications may take place, the ASU defers the sunset date of Topic 848 from December 31, 2022, to December 31, 2024, after which entities will no longer be permitted to apply the relief in Topic 848. The ASU is effective for all entities upon issuance. In March 2020, the FASB issued ASU No. 2020-04 “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” These amendments provide temporary optional guidance to ease the potential burden in accounting for reference rate reform. The ASU provides optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. It is intended to help stakeholders during the global market-wide reference rate transition period. The guidance is effective for all entities as of March 12, 2020 through December 31, 2022. Subsequently, in January 2021, the FASB issued ASU No. 2021-01 “Reference Rate Reform (Topic 848): Scope.” This ASU clarifies that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition. The ASU also amends the expedients and exceptions in Topic 848 to capture the incremental consequences of the scope clarification and to tailor the existing guidance to derivative instruments affected by the discounting transition. An entity may elect to apply ASU No. 2021-01 on contract modifications that change the interest rate used for margining, discounting, or contract price alignment retrospectively as of any date from the beginning of the interim period that includes March 12, 2020, or prospectively to new modifications from any date within the interim period that includes or is subsequent to January 7, 2021, up to the date that financial statements are available to be issued. An entity may elect to apply ASU No. 2021-01 to eligible hedging relationships existing as of the beginning of the interim period that includes March 12, 2020, and to new eligible hedging relationships entered into after the beginning of the interim period that includes March 12, 2020. The Company has identified all loans that are directly or indirectly impacted by LIBOR. Other accounting standards that have been issued by the FASB or other standards-setting bodies are not currently expected to have a material effect on the Company's financial position, results of operations or cash flows.

Adoption of New Accounting Stan

Adoption of New Accounting Standards	6 Months Ended
	Jun. 30, 2023
Accounting Changes and Error Corrections [Abstract]
Adoption of New Accounting Standards	Note 2. Adoption of New Accounting Standards Financial Instruments – Credit Losses - On January 1, 2023, the Company adopted ASU 2016-13, “Financial Instruments – Credit Losses: Measurement of Credit Losses on Financial Instruments," and ASU 2022-02, “Financial Instruments-Credit Losses, Troubled Debt Restructurings and Vintage Disclosures,” collectively referred to as ASC 326. This standard, in part, replaced the incurred loss methodology with an expected loss methodology that is referred to as the current expected credit loss ("CECL") methodology. ASC 326 requires an estimate of credit losses for the remaining estimated life of the financial assets using historical experience, current conditions, and reasonable and supportable forecasts and generally applies to financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities, and some off-balance sheet credit exposures such as unfunded commitments to extend credit. Financial assets measured at amortized cost will be presented at the net amount expected to be collected by using an allowance for credit losses. Purchased credit deteriorated loans will receive an initial allowance at the acquisition date that represents an adjustment to the amortized cost basis of the loan, with no impact to earnings. In addition, ASU 326 made changes to the accounting for available-for-sale debt securities. One change is to require credit losses to be presented as an allowance rather than as a write-down on available for sale debt securities if management does not intend to sell and does not believe that it is more likely than not, they will be required to sell. The Company adopted ASC 326 and all related subsequent amendments thereto effective January 1, 2023 using the modified retrospective approach for all financial assets measured at amortized cost and off-balance sheet credit exposures. The transition adjustment of the adoption included an increase in the ACL on loans of $ 2.5 million, which is presented as a reduction to net loans outstanding, and an increase in the ACL for unfunded loan commitments of $ 252 thousand, which is recorded within Accrued interest payable and other liabilities on the consolidated balance sheets. The Company recorded a net decrease to opening retained earnings as of January 1, 2023 of $ 1.9 million, for the cumulative effect of adopting ASC 326, which reflects the transition adjustments noted above, net of the applicable deferred tax assets recorded. Results for reporting periods beginning after January 1, 2023 are presented under ASC 326 while prior period amounts continue to be reported in accordance with previously applicable accounting standards ("Incurred Loss"). Subsequent to adoption, the Company will record adjustments to its ACL and reserve for unfunded commitments through the provision for credit losses in the consolidated statements of income. ASC 326 also replaced the Company's previous accounting policies for PCI loans and TDRs. With the adoption of ASC 326, loans previously designated as PCI loans were designated as purchased loans with credit deterioration (PCD loans). The Company adopted ASC 326 using the prospective transition approach for PCD loans that were previously identified as PCI and accounted for under ASC 310-30. On January 1, 2023, the Company's PCD loans were adjusted to reflect the addition of $ 355 thousand of expected credit losses to the amortized cost basis of the loans and a corresponding increase to the ACL. The remaining noncredit discount, the difference between the adjusted amortized cost basis and the outstanding principal balance on PCD loans, will be accreted into interest income over the estimated remaining lives of the loans using the effective interest rate method. The evaluation of the ACL will include PCD loans together with other loans that share similar risk characteristics, rather than using the separate pools that were used under PCI accounting. The adoption of ASC 326 also replaced previous TDR accounting guidance, and the evaluation of the ACL will include loans previously designated as TDRs together with other loans that share similar risk characteristics. The adoption of ASC 326 did not affect the carrying value of debt securities or the amount of unrealized gains and losses recorded in accumulated other comprehensive loss. Upon adoption of ASC 326, the Company did not have any securities included in its portfolio where OTTI had previously been recognized or that required an ACL. Therefore, the Company determined that an ACL on AFS securities was not deemed material. The following table illustrates the impact of adopting ASC 326 (dollars in thousands): December 31, 2022 January 1, 2023 January 1, 2023 As Previously Reported Impact of As Reported Under ASC 326 Assets: Loans, gross $ 936,415 $ 355 $ 936,770 Allowance for credit losses: Commercial 194 ( 11 ) 183 Real estate construction and land 221 440 661 1-4 family residential mortgages 1,618 14 1,632 Commercial mortgages 2,820 1,577 4,397 Consumer 699 471 1,171 Allowance for credit losses $ 5,552 $ 2,491 $ 8,044 Loans, net $ 930,863 $ ( 2,136 ) $ 928,726 Net deferred tax asset $ 17,315 $ 499 $ 17,814 Liabilities: Reserve for credit losses on unfunded commitments 60 253 313 Total equity $ 133,416 $ ( 1,890 ) $ 131,526 Available for Sale Securities - For AFS securities, management evaluates all investments in an unrealized loss position on a quarterly basis, and more frequently when economic or market conditions warrant such evaluation. If the Company has the intent to sell the security or it is more likely than not that the Company will be required to sell the security, the security is written down to fair value and the entire loss is recorded in earnings. If either of the above criteria is not met, the Company evaluates whether the decline in fair value is the result of credit losses or other factors. In making the assessment, the Company may consider various factors including the extent to which fair value is less than amortized cost, performance on any underlying collateral, downgrades in the ratings of the security by a rating agency, the failure of the issuer to make scheduled interest or principal payments and adverse conditions specifically related to the security. If the assessment indicates that a credit loss exists, the present value of cash flows expected to be collected are compared to the amortized cost basis of the security and any excess is recorded as an ACL, limited by the amount that the fair value is less than the amortized cost basis. Any amount of unrealized loss that has not been recorded through an ACL is recognized in other comprehensive income. Changes in the ACL are recorded as provision for (or reversal of) credit loss expense. Losses are charged against the ACL when management believes an AFS security is confirmed to be uncollectible or when either of the criteria regarding intent or requirement to sell is met. At June 30, 2023, there was no ACL related to the AFS securities portfolio. Loans - Loans that management has the intent and ability to hold for the foreseeable future or until maturity or payoff are reported at amortized cost. Amortized cost is the principal balance outstanding, net of purchase premiums and discounts and deferred fees and costs. Accrued interest receivable related to loans totaled $ 2.9 million at June 30, 2023 and was reported in Accrued interest receivable and other assets on the consolidated balance sheets. Interest income is accrued on the unpaid principal balance. Loan origination fees, net of certain direct origination costs, are deferred and recognized in interest income using methods that approximate a level yield without anticipating prepayments. The accrual of interest is generally discontinued when a loan becomes 90 days past due and is not well collateralized and in the process of collection, or when management believes, after considering economic and business conditions and collection efforts, that the principal or interest will not be collectible in the normal course of business. Past due status is based on contractual terms of the loan. A loan is considered to be past due when a scheduled payment has not been received 30 days after the contractual due date. All accrued interest is reversed against interest income when a loan is placed on nonaccrual status. Interest received on such loans is accounted for using the cost-recovery method, until qualifying for return to accrual. Under the cost-recovery method, interest income is not recognized until the loan balance is reduced to zero. Loans are returned to accrual status when all the principal and interest amounts contractually due are brought current, there is a sustained period of repayment performance, and future payments are reasonably assured. Allowance for Credit Losses - Purchased Credit Deteriorated Loans - Upon adoption of ASC 326, loans that were designated as PCI loans under the previous accounting guidance were classified as PCD loans without reassessment. In future acquisitions, the Company may purchase loans, some of which may have experienced more than insignificant credit deterioration since origination. In those cases, the Company will consider internal loan grades, delinquency status and other relevant factors in assessing whether purchased loans are PCD. PCD loans are recorded at the amount paid. An initial ACL is determined using the same methodology as other loans held for investment, but with no impact to earnings. The initial ACL determined on a collective basis is allocated to individual loans. The sum of the loan's purchase price and ACL becomes its initial amortized cost basis. The difference between the initial amortized cost basis and the par value of the loan is a noncredit discount or premium, which is amortized into interest income over the life of the loan. Subsequent to initial recognition, PCD loans are subject to the same interest income recognition and impairment model as non-PCD loans, with changes to the ACL recorded through provision expense. Allowance for Credit Losses - Loans - The ACL is a valuation account that is deducted from the loans' amortized cost basis to present the net amount expected to be collected on the loans. Loans are charged off against the allowance when management believes the uncollectibility of a loan balance is confirmed. Expected recoveries do not exceed the aggregate of amounts previously charged-off and expected to be charged-off. Accrued interest receivable is excluded from the estimate of credit losses. The ACL represents management’s estimate of lifetime credit losses inherent in loans as of the balance sheet date. The ACL is estimated by management using relevant available information, from both internal and external sources, relating to past events, current conditions, and reasonable and supportable forecasts. The Company measures expected credit losses for loans on a pooled basis when similar risk characteristics exist. The Company has identified ten portfolio segments and calculates the ACL for each using the methodology specified below (with the major classification noted in italics) : Discounted cash flow methodology: 1. Commercial and industrial (Commercial) 2. Construction (Real estate construction and land) 3. Consumer (Consumer) 4. Commercial real estate, non-owner occupied (Commercial mortgage) 5. Commercial real estate, owner occupied (Commercial mortgage) 6. Home equity and junior liens (1-4 family residential mortgage) 7. Multifamily (Commercial mortgage) 8. Residential first lien (1-4 family residential mortgage) Remaining life methodology: 9. Minute lender (Consumer/Commercial) 10. Student loans (Consumer) Additionally, the ACL calculation includes subjective adjustments for qualitative risk factors that are likely to cause estimated credit losses to differ from historical experience. These qualitative adjustments may increase reserve levels and include: adjustments for changes in lending policies and procedures and underwriting practices; changes in national, regional and local economic conditions; changes in the nature and volume of the portfolio and terms of loans; changes in the experience, depth and ability of credit and loan operations staff; changes in the volume and severity of past due, special mention and substandard loans; changes in the quality of the loan review system; changes in the value of underlying collateral for loans that are not collateral dependent; the existence and effect of any concentrations of credit and changes in the levels of such concentrations, and the effect of other external factors such as competition, legal and regulatory requirements, on the level of estimated credit losses. Loans that do not share risk characteristics are evaluated on an individual basis and are not included in the collective analysis. The ACL on loans that are individually evaluated may be estimated based on their expected cash flows, or, in the case of loans for which repayment is expected substantially through the sale of collateral, the expected credit losses are based on the fair value of collateral at the reporting dated adjusted for selling costs as appropriate. Allowance for Credit Losses – Reserve for Unfunded Commitments - The Company records an ACL for off-balance sheet credit exposures, unless the commitments to extend credit are unconditionally cancelable, through a charge to provision for credit losses in the Company’s consolidated statements of income. The ACL for off-balance sheet credit exposures is estimated by loan segment at each balance sheet date under the current expected credit loss model using the same methodologies as portfolio loans, taking into consideration the likelihood that funding will occur as well as any third-party guarantees. The allowance for unfunded commitments is included in Accrued interest and other liabilities on the Company’s consolidated balance sheets. Accrued Interest Receivable - The Company elected not to measure an ACL for accrued interest receivable and instead elected to reverse interest income on loans or securities that are placed on nonaccrual status, which is generally when the instrument is 90 days past due, or earlier if the Company believes the collection of interest is doubtful. The Company has concluded that this policy results in the timely reversal of uncollectible interest.

Securities

Securities	6 Months Ended
	Jun. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Securities	Note 3. Securities The amortized cost and fair values of securities available for sale as of June 30, 2023 and December 31, 2022 were as follows (dollars in thousands): June 30, 2023 Gross Gross Amortized Unrealized Unrealized Fair Cost Gains (Losses) Value U.S. Government treasuries $ 177,277 $ - $ ( 1,726 ) $ 175,551 U.S. Government agencies 45,179 - ( 6,340 ) 38,839 Mortgage-backed securities/CMOs 185,436 - ( 27,648 ) 157,788 Corporate bonds 19,630 - ( 928 ) 18,702 Municipal bonds 104,550 - ( 21,562 ) 82,988 Total Securities Available for Sale $ 532,072 $ - $ ( 58,204 ) $ 473,868 December 31, 2022 Gross Gross Amortized Unrealized Unrealized Fair Cost Gains (Losses) Value U.S. Government treasuries $ 245,583 $ - $ ( 3,113 ) $ 242,470 U.S. Government agencies 35,283 - ( 6,528 ) 28,755 Mortgage-backed securities/CMOs 194,964 - ( 27,888 ) 167,076 Corporate bonds 19,581 - ( 852 ) 18,729 Municipal bonds 104,831 - ( 23,675 ) 81,156 Total Securities Available for Sale $ 600,242 $ - $ ( 62,056 ) $ 538,186 As of June 30, 2023, there were $ 471.8 million or 288 issues of individual securities, held in an unrealized loss position. These securities have an unrealized loss of $ 58.2 million and consist of 120 mortgage-backed/collateralized mortgage obligations, 125 municipal bonds, 21 agency bonds, 11 treasury bonds and 11 corporate bonds. Accrued interest receivable on AFS securities as of June 30, 2023 amounted to $ 2.1 million. The following table summarizes all securities with unrealized losses, segregated by length of time in a continuous unrealized loss position, for which no allowance for credit losses was recorded, at June 30, 2023, and December 31, 2022 (dollars in thousands): Less than 12 Months 12 Months or More Total June 30, 2023 Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses U.S. Government treasuries $ 84,250 $ ( 238 ) $ 91,301 $ ( 1,488 ) $ 175,551 $ ( 1,726 ) U.S. Government agencies 10,107 ( 53 ) 28,731 ( 6,287 ) 38,838 ( 6,340 ) Mortgage-backed/CMOs 13,028 ( 730 ) 144,760 ( 26,918 ) 157,788 ( 27,648 ) Corporate bonds 9,628 ( 403 ) 9,075 ( 525 ) 18,703 ( 928 ) Municipal bonds 3,123 ( 102 ) 77,843 ( 21,460 ) 80,966 ( 21,562 ) $ 120,136 $ ( 1,526 ) $ 351,710 $ ( 56,678 ) $ 471,846 $ ( 58,204 ) Less than 12 Months 12 Months or More Total December 31, 2022 Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses U.S. Government treasuries $ 242,470 $ ( 3,113 ) $ - $ - $ 242,470 $ ( 3,113 ) U.S. Government agencies 4,285 ( 620 ) 24,218 ( 5,908 ) 28,503 ( 6,528 ) Mortgage-backed/CMOs 55,396 ( 6,010 ) 111,689 ( 21,878 ) 167,085 ( 27,888 ) Corporate bonds 18,729 ( 852 ) - - 18,729 ( 852 ) Municipal bonds 44,117 ( 8,001 ) 35,964 ( 15,674 ) 80,081 ( 23,675 ) $ 364,997 $ ( 18,596 ) $ 171,871 $ ( 43,460 ) $ 536,868 $ ( 62,056 ) The Company’s securities portfolio is primarily made up of fixed rate instruments, the prices of which move inversely with interest rates. Any unrealized losses are considered by management to be driven by increases in market interest rates over the yields available at the time the underlying securities were purchased. The fair value is expected to recover as the instruments approach their maturity date or repricing date or if market yields for such investments decline. At the end of any accounting period, the portfolio may have both unrealized gains and losses. Impairment of debt securities occurs when the fair value of a security is less than its amortized cost. The Company has elected to exclude accrued interest receivable from the amortized cost basis. For debt securities AFS, impairment is recognized in its entirety in net income if either (i) we intend to sell the security or (ii) it is more-likely-than-not that we will be required to sell the security before recovery of its amortized cost basis. If, however, the Company does not intend to sell the security and it is not more-likely-than-not that the Company will be required to sell the security before recovery, the Company evaluates unrealized losses to determine whether a decline in fair value below amortized cost basis is a result of a credit loss, which occurs when the amortized cost basis of the security exceeds the present value of the cash flows expected to be collected from the security, or other factors such as changes in market interest rates. If a credit loss exists, an ACL is recorded that reflects the amount of the impairment related to credit losses, limited by the amount by which the security’s amortized cost basis exceeds its fair value. Changes in the ACL are recorded in net income in the period of change and are included in provision for credit losses. Changes in the fair value of debt securities AFS not resulting from credit losses are recorded in other comprehensive income (loss). The Company regularly reviews unrealized losses in its investments in securities and cash flows expected to be collected from impaired securities based on criteria including the extent to which market value is below amortized cost, the financial health of and specific prospects for the issuer, the Company’s intention with regard to holding the security to maturity and the likelihood that the Company would be required to sell the security before recovery. Management does not believe any of the securities in an unrealized loss position are impaired due to credit quality. In addition, issuers have continued to make timely payments of principal and interest. Accordingly, as of June 30, 2023, management believes the impairments detailed in the table above are temporary, and no credit loss has been realized in the Company’s consolidated income statement. Additionally, management has the ability to hold any security with an unrealized loss until maturity or until such time as the value of the security has recovered from its unrealized loss position. Securities having carrying values of $ 3.1 million and $ 3.0 million at June 30, 2023 and December 31, 2022, respectively, were pledged as collateral to facilitate borrowing from the Federal Reserve Bank of Richmond. Securities having carrying values of $ 18.2 million and $ 2.1 million at June 30, 2023 and December 31, 2022, respectively, were pledged to the Commonwealth of Virginia Department of the Treasury to secure public funds depository accounts. During the six months ended June 30, 2023 , the Company sold AFS securities with a total book value of $ 49.9 million, incurring a pre-tax loss of $ 206 thousand, and used the net proceeds to fund normal daily operating demands. There were no sales of securities during the three months ended June 30, 2023 or the three and six months ending June 30, 2022. Restricted securities are securities with limited marketability and consist of stock in the FRB, the Federal Home Loan Bank of Atlanta, CBB Financial Corporation (the holding company for Community Bankers' Bank) and an investment in an SBA loan fund. These restricted securities, totaling $ 7.4 million and $ 5.1 million as of June 30, 2023 and December 31, 2022, respectively, are carried at cost. The amortized cost and fair value of AFS debt securities at June 30, 2023 are presented below based upon contractual maturities, by major investment categories (dollars in thousands). Expected maturities may differ from contractual maturities because issuers have the right to call or prepay obligations. Amortized Cost Fair Value U.S. Government treasuries One year or less $ 165,818 $ 164,439 After one year to five years 11,459 11,112 $ 177,277 $ 175,551 U.S. Government agencies One year or less $ 10,000 $ 9,948 After one year to five years 5,802 5,049 After five years to ten years 25,377 20,918 Ten years or more 4,000 2,924 $ 45,179 $ 38,839 Mortgage-backed securities/CMOs One year or less $ 2,954 $ 2,890 After one year to five years 6,452 6,051 After five years to ten years 3,185 2,878 Ten years or more 172,845 145,969 $ 185,436 $ 157,788 Corporate bonds One year or less $ 1,002 $ 977 After one year to five years 18,628 17,725 $ 19,630 $ 18,702 Municipal bonds After one year to five years $ 3,060 $ 2,922 After five years to ten years 19,892 18,089 Ten years or more 81,598 61,977 $ 104,550 $ 82,988 Total Debt Securities Available for Sale $ 532,072 $ 473,868

Loans

Loans	6 Months Ended
	Jun. 30, 2023
Loans and Leases Receivable Disclosure [Abstract]
Loans	Note 4. Loans On January 1, 2023, the Company adopted ASC 326. The measurement of expected credit losses under the CECL methodology is applicable to financial assets measured at amortized cost, including loans receivable. For further information and discussion regarding the Company's accounting policies and policy elections related to the accounting standard update, see Note 1 - Summary of Significant Accounting Policies. All loan information presented as of June 30, 2023 is in accordance with ASC 326. All loan information presented as of December 31, 2022 or a prior date is presented in accordance with previously applicable GAAP. The composition of the loan portfolio by major loan classifications at June 30, 2023 and December 31, 2022 , stated at their face amount, net of deferred fees and costs and discounts, including fair value marks, appears below (dollars in thousands). The Company has elected to exclude accrued interest receivable, totaling $ 2.9 million as of June 30, 2023, from the amortized cost basis of loans. June 30, December 31, 2023 2022 Commercial $ 98,312 $ 71,139 Real estate construction and land 29,825 37,541 1-4 family residential mortgages 317,330 323,185 Commercial mortgages 486,643 459,125 Consumer 41,238 45,425 Total loans 973,348 936,415 Less: Allowance for credit losses ( 7,863 ) ( 5,552 ) Net loans $ 965,485 $ 930,863 The balances in the table above include unamortized premiums and net deferred loan costs and fees. As of June 30, 2023 and December 31, 2022, unamortized premiums from purchases of loans (excluding loans acquired during the Merger) were $ 1.8 million , remaining rather consistent due to purchases of loans with premiums, offset by amortization of existing premiums. Net deferred loan fees totaled $ 1.7 million and $ 755 thousand as of June 30, 2023 and December 31, 2022, respectively. Consumer loans inclu de $ 58 thousand and $ 180 thousand of demand deposit overdrafts as of June 30, 2023 and December 31, 2022, respectively. Loans acquired in business combinations are recorded in the consolidated balance sheets at fair value at the acquisition date under the acquisition method of accounting. The fair value mark as of the Effective Date w as $ 23.1 million. The table above includes a remaining net fair value mark of $ 11.0 million as of June 30, 2023 on the Acquired Loans. The following table shows the aging of the Company's loan portfolio, by class, at June 30, 2023 (dollars in thousands): 30-59 Days 60-89 Days 90 Days or More Past Due and Still Accruing Nonaccrual Loans Current Loans Total Loans Commercial $ 793 $ - $ - $ - $ 97,519 $ 98,312 Real estate construction and land - - - - 29,825 29,825 1-4 family residential mortgages 292 59 - 713 316,266 317,330 Commercial mortgages 439 - - 472 485,732 486,643 Consumer loans 264 1 107 - 40,866 41,238 Total Loans $ 1,788 $ 60 $ 107 $ 1,185 $ 970,208 $ 973,348 The following table shows the Company's amortized cost basis of loans on nonaccrual status as of June 30, 2023 and December 31, 2022 (dollars in thousands). All nonaccrual loans are evaluated for an ACL on an individual basis. Only one nonaccrual loan required an ACL, in the amount of $ 19 thousand, due to collateral value shortfall. The adoption of CECL altered the manner in which purchased loans that were in non-accrual status are presented, and as a result, two such loans totaling $ 534 thousand are included in this figure in 2023 and not included in 2022. CECL Incurred Loss June 30, 2023 December 31, 2022 Nonaccrual Loans with No Allowance Nonaccrual Loans with an Allowance Total Nonaccrual Loans Nonaccrual Loans Commercial $ - $ - $ - $ - Real estate construction and land - - - - 1-4 family residential mortgages 233 480 713 673 Commercial mortgages 472 472 - Consumer - - - - Total Loans $ 705 $ 480 $ 1,185 $ 673 From time to time, the Company modifies loans to borrowers who are experiencing financial difficulties by providing term extensions, interest rate reductions or other-than-insignificant payment delays. As the effect of most modifications is already included in the ACL due to the measurement methodologies used in its estimate, the ACL is typically not adjusted upon modification. During the three and six months ended June 30, 2023, no loans were modified for borrowers experiencing financial difficulties. The Company closely monitors the performance of all modified loans to understand the effectiveness of its modification efforts. Upon determination, if applicable, that all or a portion of a modified loan is uncollectible, that amount is charged against the ACL. There were no payment defaults during the three months ended June 30, 2023 of modified loans that were modified during the previous twelve months and all are current as of June 30, 2023. Prior to the adoption of ASC 326 Loans acquired in business combinations are recorded in the consolidated balance sheets at fair value at the acquisition date under the acquisition method of accounting. The outstanding principal balance and the carrying amount at December 31, 2022 of loans acquired in business combinations were as follows (dollars in thousands): December 31, 2022 Acquired Loans - Acquired Loans - Purchased Performing Acquired Outstanding principal balance $ 43,250 $ 290,604 $ 333,854 Carrying amount: Commercial $ 630 $ 12,606 $ 13,236 Real estate construction and land 1,461 8,530 9,991 1-4 family residential mortgages 9,076 164,280 173,356 Commercial mortgages 20,828 99,206 120,034 Consumer 72 1,277 1,349 Total acquired loans $ 32,067 $ 285,899 $ 317,966 The following table presents a summary of the changes in the accretable yield of loans classified as purchased credit impaired (dollars in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2022 Accretable yield, beginning of period 12,428 13,742 Accretion ( 761 ) ( 1,500 ) Reclassification from nonaccretable difference - 2,193 Other changes, net - ( 2,768 ) Accretable yield, end of period 11,667 11,667 The past due status of loans as of December 31, 2022 was as follows (dollars in thousands): 30-59 Days 60-89 Days 90 Days or More Total PCI Current Total 90 Days Past Due and Still Accruing Commercial $ - $ 24 $ - $ 24 $ 630 $ 70,485 $ 71,139 $ - Real estate construction and land 287 - 75 362 1,461 35,718 37,541 - 1-4 family residential mortgages 1,176 191 598 1,965 9,076 312,144 323,185 - Commercial mortgages 330 - 646 976 20,828 437,321 459,125 646 Consumer loans 315 41 59 415 72 44,938 45,425 59 Total Loans $ 2,108 $ 256 $ 1,378 $ 3,742 $ 32,067 $ 900,606 $ 936,415 $ 705 The following table provides a summary, by class, of TDRs as of December 31, 2022 that continued to accrue interest under the terms of the restructuring agreement, which were considered to be performing, and TDRs that were placed in nonaccrual status which were considered to be nonperforming (dollars in thousands): Troubled debt restructurings December 31, 2022 No. of Recorded Loans Investment Performing TDRs 1-4 family residential mortgages 1 $ 88 Consumer 46 700 Total performing TDRs 47 $ 788 Nonperforming TDRs 1-4 family residential mortgages 2 $ 495 Consumer - - Total nonperforming TDRs 2 495 Total TDRs 49 $ 1,283 There were no defaults in the three months ended June 30, 2022 on loans modified in the previous twelve months.

Allowance for Credit Losses

Allowance for Credit Losses	6 Months Ended
	Jun. 30, 2023
Allowance For Loan Losses [Abstract]
Allowance for Credit Losses	Note 5. Allowance for Credit Losses On January 1, 2023, the Company adopted ASC 326. The measurement of expected credit losses under the CECL methodology is applicable to financial assets measured at amortized cost. For further information and discussion regarding the Company's accounting policies and policy elections related to the accounting standard update, see Note 1 - Summary of Significant Accounting Policies. All ACL information presented as of June 30, 2023 is in accordance with ASC 326. All ALLL information presented as of December 31, 2022 or a prior date is presented in accordance with previously applicable GAAP. The ACL on the loan portfolio is a material estimate for the Company. The Company estimates is ACL on its loan portfolio on a quarterly basis. The Company utilizes two methodologies in its development of the ACL, discounted cash flow and remaining life. • Discounted Cash Flow o DCF models, being periodic in nature, allow for effective incorporation of a reasonable and supportable forecast in a directionally consistent and objective manner. o The analysis aligns well with other calculations/actions outside the ACL estimation, which will mitigate model risk in other areas and allow for symmetrical application. For example, fair value (exit price notion), profitability analysis, IRR calculations, ALM, stress testing, and other forms of cash flow analysis. o Peer data is available for certain inputs (Probability of Default, Loss Given Default) if first-party data is not available or meaningful. This is made possible by the periodic nature of the model. o The DCF methodology is utilized on the following pools: 1) Commercial & Industrial; 2) Construction; 3) Consumer; 4) CRE NonOwner Occupied; 5) CRE Owner Occupied; 6) HELOC & Junior Lien; 7) Residential 1st Lien; and 8) Multifamily. • Remaining Life o This methodology leverages a quarterly loss rate as well as future expectations of portfolio balances to calculate a reserve. o There are two main strengths of this methodology. First, it is fairly easy to execute and does not rely on large quantities of historical loan-level data. Second, it can satisfy the need to incorporate a reasonable and supportable forecast in a straightforward manner by either applying a forecast policy of “applicable history” or leveraging an actual econometric model for the analysis. o The remaining life methodology is utilized on the following pools: 1) Minute Lender; and 2) Student Loans. Maximum Loss Rate - Management utilizes the same model to calculate maximum loss rates and expected loss rates for each segment. No additional models or methodologies were used to quantify the maximum loss rate, rather, a worst-case economic environment is utilized in the models. This process ensures symmetry between the maximum loss rate and the quantified loss rate. This process also leverages the well-documented regression models used in model development. The process for deriving the maximum loss rate is outlined below: • The economic forecast reflects the worst economic environment observed for each economic factor. This is done by quantifying a rolling 1-year average for each economic factor. Then, the most pessimistic 1-year average observations are captured and utilized as economic forecast inputs within the application. • The economic forecast assumed is a ‘worst-case’ economic environment with inputs reflective of the great recession. • The economic forecast is used to quantify credit risk in the form of Loss Rate. The resulting periodic default and loss rates are applied to the prepayment adjusted amortization schedules for each segment. • The resulting ACL, which represents a lifetime reserve (symmetrical to the base model), is input into the qualitative framework’s maximum loss rate field. The difference between the expected model and the maximum model results are then allocated based on weight and risk assignment. Qualitative Factors - ASC 326 requires an entity to adjust historical loss information to reflect the extent to which management expects reasonable and supportable forecasts to differ from the conditions that existed for the period over which historical information was evaluated. The adjustments for reasonable and supportable forecasts may be qualitative in nature and should reflect changes related to relevant data. The Company utilizes a scorecard approach to assign qualitative factors. The scorecard approach is in alignment with the AICPA audit considerations for CECL which states: These adjustments should be grounded in a methodology that is subject to appropriate governance, challenge, and periodic controlled reevaluation. Such methodology will generally require significant management judgment. The information used to support management’s adjustments may be publicly available information, information specifically developed for the entity via management’s specialist (internal or external), or other relevant and reliable information. The purpose of the qualitative scorecard is to provide a qualitative estimate of the expected credit losses of the current loan portfolio in response to potential limitations of the quantitative model. It is used to aid in the assessment of the unquantifiable factors affecting expected credit losses in the loan portfolio. Benefits of the scorecard include directional consistency, objectivity, controls and quantification framework (auditable). For each segment, the scorecard calculates the difference between the quantitative expected credit loss and the maximum loss rate. This difference represents all available qualitative adjustment that can be applied to that segment. Individual Evaluation - In accordance with ASC 326, the Company will evaluate individual loans for expected credit losses when those loans do not share similar risk characteristics with loans evaluated using a collective (pooled) basis. Loans will not be included in both collective and individual analysis. Individual analysis will establish a specific reserve for each loan, using one of four methods: 1) Fair Value of Collateral Method (Collateral Relationship); 2) Cash Flow Method; 3) Advanced Cash Flow Method; or 4) Loan Pricing Method. Management has elected to perform an individual evaluation on all loans in non-accrual status. As of June 30, 2023 , after reviewing each loan in non-accrual status, a specific reserve of $ 19 thousand was established. The primary driver in the increase in reserves from adoption date of January 1, 2023 to June 30, 2023 was the increase in outstanding loan balances. The following table shows the ACL activity by loan portfolio for the three and six months ended June 30, 2023 (dollars in thousands): Commercial Real Estate 1-4 family residential mortgages Commercial mortgages Consumer Total Allowance for Credit Losses: Balance as of December 31, 2022 $ 194 $ 221 $ 1,618 $ 2,820 $ 699 $ 5,552 Impact of ASC 326 adoption ( 11 ) 440 14 1,577 471 2,491 Charge-offs - - - - ( 142 ) ( 142 ) Recoveries - - 3 41 62 106 Provision for (recovery of) credit ( 7 ) ( 90 ) ( 75 ) 33 ( 96 ) ( 235 ) Balance as of March 31, 2023 $ 176 $ 571 $ 1,560 $ 4,471 $ 994 $ 7,772 Charge-offs - - - - ( 180 ) ( 180 ) Recoveries 20 - 2 - 33 55 Provision for (recovery of) credit 19 ( 107 ) 715 ( 516 ) 105 216 Balance as of June 30, 2023 $ 215 $ 464 $ 2,277 $ 3,955 $ 952 $ 7,863 The following table presents a breakdown of the provision for credit losses for the periods indicated (dollars in thousands): Three Months Ended Six Months Ended June 30, 2023 June 30, 2022 June 30, 2023 June 30, 2022 Provision for credit losses: Provision (recovery) for loans $ 216 $ ( 217 ) $ ( 19 ) $ ( 69 ) Provision for unfunded commitments 45 - 32 - Total $ 261 $ ( 217 ) $ 13 $ ( 69 ) The following table presents the Company's amortized cost basis of collateral dependent loans, which are individually evaluated to determine expected credit losses, and the related ACL allocated to those loans as of June 30, 2023 (dollars in thousands): June 30, 2023 Real Estate Secured Loans Allowance for Credit Losses -Loans Commercial real estate - non owner occupied $ 698 $ - Residential 1-4 family real estate 741 19 Total $ 1,439 $ 19 The following table presents the Company's recorded investment in loans by credit quality indicators by year of origination as of June 30, 2023 (dollars in thousands). Current period gross write-off amounts represent write-offs for the six months ended June 30, 2023 (dollars in thousands): June 30, 2023 Term Loans Amortized Cost Basis by Origination Year 2023 2022 2021 2020 2019 Prior Revolving Loans Loans Converted to Term Total Commercial Pass $ 28,457 $ 12,818 $ 3,101 $ 5,959 $ 8,560 $ 15,005 $ 22,694 $ 14 $ 96,608 Watch - 44 - - 122 7 7 - 180 Special Mention - - 1 - - 93 215 - 309 Substandard - 73 10 40 344 261 - 487 1,215 Total commercial $ 28,457 $ 12,935 $ 3,112 $ 5,999 $ 9,026 $ 15,366 $ 22,916 $ 501 $ 98,312 Current period gross write-off $ - $ - $ - $ - $ - $ - $ - $ - $ - . Real estate construction and land Pass $ 3,665 $ 13,539 $ 4,512 $ 1,754 $ 940 $ 2,932 $ - $ - $ 27,342 Watch - - - - - 329 - - 329 Special Mention - - - - - 750 - - 750 Substandard - - - - 364 1,040 - - 1,404 Total real estate construction and land $ 3,665 $ 13,539 $ 4,512 $ 1,754 $ 1,304 $ 5,051 $ - $ - $ 29,825 Current period gross write-off $ - $ - $ - $ - $ - $ - $ - $ - $ - . 1-4 family residential mortgages Pass $ 9,025 $ 14,994 $ 57,925 $ 77,837 $ 25,810 $ 93,193 $ 23,425 $ 387 $ 302,596 Watch - 1,396 125 1,449 - 6,025 470 - 9,465 Special Mention - 853 127 - - 1,389 78 - 2,447 Substandard - - 55 507 99 2,161 - - 2,822 Total 1-4 family residential mortgage $ 9,025 $ 17,243 $ 58,232 $ 79,793 $ 25,909 $ 102,768 $ 23,973 $ 387 $ 317,330 Current period gross write-off $ - $ - $ - $ - $ - $ - $ - $ - $ - . Commercial mortgages Pass $ 48,144 $ 40,929 $ 48,145 $ 105,357 $ 36,869 $ 168,088 $ 2,518 $ - $ 450,050 Watch - - 265 178 7,311 13,216 - - 20,970 Special Mention - - 394 291 - 4,257 - - 4,942 Substandard 156 - 1,860 2,838 - 5,827 - - 10,681 Total commercial mortgages $ 48,300 $ 40,929 $ 50,664 $ 108,664 $ 44,180 $ 191,388 $ 2,518 $ - $ 486,643 Current period gross write-off $ - $ - $ - $ - $ - $ - $ - $ - $ - Consumer Pass $ 76 $ 237 $ 587 $ 412 $ 179 $ 24,303 $ 14,389 $ 40,183 Watch - - - 15 12 825 - 852 Special Mention - - - - - 75 1 9 85 Substandard - - 3 - 8 107 - 118 Total consumer $ 76 $ 237 $ 590 $ 427 $ 199 $ 25,310 $ 14,390 $ 9 $ 41,238 Current period gross write-off $ - $ - $ 17 $ 1 $ 27 $ 273 $ 4 $ - $ 322 Credit Quality Indicators The Company utilizes the following credit quality indicators: Pass Loans with the following risk ratings are pooled by class and considered together as “Pass”: Excellent – minimal risk loans secured by cash or fully guaranteed by a U.S. government agency Good – low risk loans secured by marketable collateral within margin Satisfactory – modest risk loans where the borrower has strong and liquid financial statements and more than adequate cash flow Average – average risk loans where the borrower has reasonable debt service capacity Marginal – acceptable risk loans where the borrower has acceptable financial statements but is leveraged Watch These loans have an acceptable risk but require more attention than normal servicing. Special Mention These potential problem loans are currently protected but are potentially weak. Substandard These problem loans are inadequately protected by the sound worth and paying capacity of the borrower and/or the value of any collateral pledged. These loans may be considered impaired and evaluated on an individual basis. Doubtful Loans with this rating have significant deterioration in the sound worth and paying capacity of the borrower and/or the value of any collateral pledged, making collection or liquidation of the loan in full highly questionable. These loans would be considered impaired and evaluated on an individual basis. Prior to the adoption of ASC 326 The following table presents the changes in the ACL by major classification during the year ended December 31, 2022 (dollars in thousands): Commercial Real Estate Real Estate Consumer Total Allowance for Credit Losses: Balance as of beginning of year $ 252 $ 399 $ 4,478 $ 855 $ 5,984 Charge-offs ( 600 ) - - ( 655 ) ( 1,255 ) Recoveries 519 9 11 178 717 Provision for (recovery of) loan losses 23 ( 187 ) ( 51 ) 321 106 Ending Balance $ 194 $ 221 $ 4,438 $ 699 $ 5,552 Ending Balance: Individually evaluated for impairment $ - $ - $ - $ 23 $ 23 Collectively evaluated for impairment 194 221 4,438 676 5,529 Acquired loans - purchased credit - - - - - Loans: Individually evaluated for impairment $ - $ - $ 583 $ 700 $ 1,283 Collectively evaluated for impairment 70,509 36,080 751,823 44,653 903,065 Acquired loans - purchased credit impaired 630 1,461 29,904 72 32,067 Ending Balance $ 71,139 $ 37,541 $ 782,310 $ 45,425 $ 936,415 The following represents the loan portfolio designated by the internal risk ratings assigned to each credit as of December 31, 2022 (dollars in thousands). There were no loans rated “Doubtful” as December 31, 2022. December 31, 2022 Excellent Good Pass Watch Special Sub- TOTAL Commercial $ 30,121 $ 16,058 $ 22,853 $ 992 $ 122 $ 993 $ 71,139 Real estate construction and land - - 35,258 342 532 1,409 $ 37,541 1-4 family residential mortgages - - 308,041 7,935 5,431 1,778 $ 323,185 Commercial mortgages - - 408,513 34,828 3,872 11,912 $ 459,125 Consumer 461 17,544 26,326 977 22 95 $ 45,425 Total Loans $ 30,582 $ 33,602 $ 800,991 $ 45,074 $ 9,979 $ 16,187 $ 936,415

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	6 Months Ended
	Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Note 6. Goodwill and Other Intangible Assets The carrying amount of goodwill was $ 7.8 million at June 30, 2023 and December 31, 2022 and $ 8.1 million as of June 30, 2022. The reduction from June 30, 2022 to the other periods presented resulted from the sale of Sturman Wealth Advisors in December of 2022 and the elimination of associated goodwill of $ 372 thousand. The Company had $ 5.8 million , $ 6.6 million and $ 7.6 million of other intangible assets as of June 30, 2023, December 31, 2022 and June 30, 2022 , respectively. Other intangible assets were recognized in connection with (i) the book of business, including interest in the client relationships of an officer, in connection with the acquisition of Sturman Wealth Advisors in 2016, and (ii) the core deposits acquired from Fauquier in 2021. The other intangible assets related to Sturman Wealth Advisors were eliminated from the balance sheet in December of 2022 upon sale of the business line. The following table summarizes the gross carrying amounts and accumulated amortization of other intangible assets (dollars in thousands): June 30, 2023 December 31, 2022 June 30, 2022 Gross Carrying Amount Accumulated Amortization Gross Carrying Amount Accumulated Amortization Gross Carrying Amount Accumulated Amortization Amortized intangible assets: Core deposit intangible $ 9,660 $ ( 3,845 ) $ 9,660 $ ( 3,074 ) $ 9,660 $ ( 2,255 ) Customer relationships intangible - - - - 773 ( 533 ) Total $ 9,660 $ ( 3,845 ) $ 9,660 $ ( 3,074 ) $ 10,433 $ ( 2,788 ) Amortization expense was $ 379 thousand and $ 444 thousand for the three months ended June 30, 2023 and 2022, respectively and $ 770 thousand and $ 900 thousand for the six months ended June 30, 2023 and 2022, respectively. Note that the amortization expense amounts for 2022 included intangible amortization expense of Sturman Wealth. Estimated future amortization expense as of June 30, 2023 is as follows (dollars in thousands): Core Deposit Intangible For the six months ending December 31, 2023 $ 722 For the year ending December 31, 2024 1,301 For the year ending December 31, 2025 1,110 For the year ending December 31, 2026 918 For the year ending December 31, 2027 726 Thereafter 1,038 Total $ 5,815

Leases

Leases	6 Months Ended
	Jun. 30, 2023
Leases [Abstract]
Leases	Note 7. Leases Lease liabilities represent the Company’s obligation to make lease payments and are presented at each reporting date as the net present value of the remaining contractual cash flows. Cash flows are discounted at the Company’s incremental borrowing rate in effect at the commencement date of the lease for a term similar to the length of the lease, including any probable renewal options available. Right-of-use assets represent the Company’s right to use the underlying asset for the lease term and are calculated as the sum of the lease liability and if applicable, prepaid rent, initial direct costs and any incentives received from the lessor. Lease payments for short-term leases are recognized as lease expense on a straight-line basis over the lease term. Payments for leases with terms longer than twelve months are included in the determination of the lease liability. Each of the Company’s long-term lease agreements is classified as an operating lease. Certain of these leases offer the option to extend the lease term and the Company has included such extensions in its calculation of the lease liabilities to the extent the options are reasonably assured of being exercised. The lease agreements do not provide for residual value guarantees and have no restrictions or covenants that would impact dividends or require incurring additional financial obligations. The following tables present information about the Company’s leases (dollars in thousands): June 30, 2023 June 30, 2022 Lease liability $ 6,301 $ 6,925 Right-of-use asset $ 6,634 $ 7,343 Weighted average remaining lease term 5.03 years 5.84 years Weighted average discount rate 2.07 % 1.97 % Three Months Ended June 30, Six Months Ended June 30, Lease Expense: 2023 2022 2023 2022 Operating lease expense $ 395 $ 449 $ 906 $ 894 Short-term lease expense 81 139 204 191 Total lease expense $ 476 $ 588 $ 1,110 $ 1,085 Cash paid for amounts included in $ 336 $ 418 $ 848 $ 832 A maturity analysis of operating lease liabilities and reconciliation of the undiscounted cash flows to the total of operating lease liabilities is as follows (dollars in thousands): Undiscounted Cash Flow June 30, 2023 Six months ending December 31, 2023 $ 694 Twelve months ending December 31, 2024 1,332 Twelve months ending December 31, 2025 1,248 Twelve months ending December 31, 2026 907 Twelve months ending December 31, 2027 811 Thereafter 1,665 Total undiscounted cash flows $ 6,657 Less: Discount ( 356 ) Lease liability $ 6,301

Net Income Per Share

Net Income Per Share	6 Months Ended
	Jun. 30, 2023
Earnings Per Share [Abstract]
Net Income Per Share	Note 8. Net Income Per Share The table below shows the weighted average number of shares used in computing net income per common share and the effect of the weighted average number of shares of potential dilutive common stock for the three and six months ended June 30, 2023 and 2022. Diluted net income per share is computed based on the weighted average number of shares of common stock equivalents outstanding, to the extent dilutive. The Company’s common stock equivalents relate to outstanding common stock options. The recipients of unvested restricted shares have full voting and dividend rights, and as such, unvested restricted stock as of June 30, 2023 and June 30, 2022 is included in the calculation of basic and diluted net income per share (dollars below reported in thousands except per share data). Three Months Ended June 30, 2023 June 30, 2022 Net Weighted Per Net Weighted Per Basic net income per share $ 5,651 5,357,873 $ 1.05 $ 5,685 5,326,271 $ 1.07 Effect of dilutive stock options - 17,200 - - 20,737 ( 0.01 ) Diluted net income per share $ 5,651 5,375,073 $ 1.05 $ 5,685 5,347,008 $ 1.06 Six Months Ended June 30, 2023 June 30, 2022 Net Weighted Per Net Weighted Per Basic net income per share $ 11,442 5,348,040 $ 2.14 $ 10,609 5,319,166 $ 1.99 Effect of dilutive stock options - 27,505 ( 0.01 ) - 26,076 ( 0.01 ) Diluted net income per share $ 11,442 $ 5,375,545 $ 2.13 $ 10,609 5,345,242 $ 1.98 For the three and six months ended June 30, 2023, there were 105,501 opti on shares considered anti-dilutive and excluded from this calculation. For the three and six months ended June 30, 2022, there were 101,901 o ption shares considered anti-dilutive and excluded from this calculation.

Stock Incentive Plans

Stock Incentive Plans	6 Months Ended
	Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]
Stock Incentive Plans	Note 9. Stock Incentive Plans At the Annual Shareholders Meeting on June 23, 2022, shareholders approved the Virginia National Bankshares Corporation 2022 Stock Incentive Plan. The 2022 Plan made available up to 150,000 shares of the Company’s common stock to be issued to plan participants. The 2014 Plan made available up to 275,625 shares of the Company’s common stock, as adjusted by prior issued stock dividends, to be issued to plan participants. The 2022 Plan and the 2014 Plan provide for granting of both incentive and nonqualified stock options, as well as restricted stock, unrestricted stock and other stock based awards. No new grants can be issued under the 2005 Stock Incentive Plan as this plan has expired. For the 2022 Plan, the option price for any stock options cannot be less that the fair value of the Company’s stock on the grant date. In addition, 95 % of the common stock authorized for issuance must have a vesting or exercise schedule of at least one year. For the 2014 Plan and the 2005 Plan, the option price of incentive stock options cannot be less than the fair value of the stock at the time an option is granted and nonqualified stock options may be granted at prices established by the Board of Directors, including prices less than the fair value on the date of grant. Outstanding stock options generally expire ten years from the grant date. Stock options generally vest by the fourth or fifth anniversary of the date of the grant. A summary of the shares issued and available under each of the Plans is shown below as of June 30, 2023 . Share data and exercise price range per share have been adjusted to reflect prior issued stock dividends. Although the 2005 Plan has expired and no new grants will be issued under this plan, there were options issued before the plan expired that are still outstanding as shown below. 2022 Plan 2014 Plan 2005 Plan Aggregate shares issuable 150,000 275,625 253,575 Options issued, net of forfeited and expired - ( 173,706 ) ( 59,870 ) Unrestricted stock issued - ( 11,635 ) - Restricted stock grants issued, net of forfeited ( 18,932 ) ( 84,253 ) - Cancelled due to Plan expiration - - ( 193,705 ) Remaining available for grant 131,068 6,031 - Stock grants issued and outstanding: Total vested and unvested shares 18,932 95,888 - Fully vested shares - 48,675 - Option grants issued and outstanding: Total vested and unvested shares - 170,501 - Fully vested shares - 109,616 - Exercise price range $ - $ 23.75 to $ 42.62 $ - The Company accounts for all of its stock incentive plans under recognition and measurement accounting principles which require that the compensation cost relating to stock-based payment transactions be recognized in the financial statements. Stock-based compensation arrangements include stock options and restricted stock. All stock-based payments to employees are required to be valued at a fair value on the date of grant and expensed based on that fair value over the applicable vesting period. Stock Options Changes in the stock options outstanding related to the Plans are summarized below (dollars in thousands except per share data): June 30, 2023 Number of Options Weighted Aggregate Outstanding at January 1, 2023 168,280 $ 33.95 $ 830 Issued 3,600 $ 35.13 Exercised ( 1,379 ) $ ( 13.69 ) Expired - $ - Outstanding at June 30, 2023 170,501 $ 34.14 $ 488 Options exercisable at June 30, 2023 109,616 $ 36.72 $ 222 For the three months ended June 30, 2023 and 2022 , the Company recognized $ 68 thousand and $ 41 thousand, respectively, in compensation expense for stock options. For the six months ended June 30, 2023 and 2022 , the Company recognized $ 110 thousand and $ 83 thousand, respectively, in c ompensation expense for stock options. As of June 30, 2023, there wa s $ 153 thousand in unr e cognized compensation expense remaining to be recognized in future reporting periods through 2026 . The fair value of any stock option grant is estimated at the grant date using the Black-Scholes pricing model. There were stock options grants of 3,600 issued during the three months ended June 30, 2023 and none granted during the first quarter of 2023. There were no stock option grants issued during the three and six months ended June 30, 2022. Summary information pertaining to options outstanding at June 30, 2023 is shown below. Share and per share data have been adjusted to reflect the prior stock dividends issued. Options Outstanding Options Exercisable Exercise Price Number of Weighted- Weighted- Number of Weighted- $ 23.75 to $ 30.00 65,000 7.0 Years $ 24.65 30,600 $ 24.90 $ 30.01 to $ 40.00 48,020 7.3 Years $ 36.83 21,536 $ 37.79 $ 40.01 to $ 42.62 57,481 4.9 Years $ 42.62 57,480 $ 42.62 Total 170,501 6.4 Years $ 34.14 109,616 $ 36.72 Stock Grants Unrestricted stock grant – No unrestricted stock grants were awarded during the six months ended June 30, 2023. During the six months ended June 30, 2022 , 100 shares of unrestricted stock were granted to an employee for a total expense of $ 3 thousand. Restricted stock grants – 8,400 and 18,932 restricted shares were granted to employees and non-employee directors, respectively, vesting over a four-year period, during the six months ended June 30, 2023. (Note that all such shares were granted during the second quarter of 2023 with no shares granted during the first quarter of 2023.) During the six months ended June 30, 2022 , 5,580 and 12,856 restricted shares, were granted to employees and non-employee directors, respectively, vesting over a four-year or five-year period. (Note that all such shares were granted during the first quarter of 2022 with no shares granted during the second quarter of 2022.) For the three and six months ended June 30, 2023 , $ 120 and $ 231 thousand, respectively, was expensed as a result of restricted stock grants. As of June 30, 2023 , there was $ 1.9 million in unrecognized compensation expense for all restricted stock grants remaining to be recognized in future reporting periods through 2027 . Changes in the restricted stock grants outstanding during the six months ended June 30, 2023 are summarized below (dollars in thousands except per share data): June 30, 2023 Number of Weighted Aggregate Nonvested as of January 1, 2023 51,664 $ 32.05 $ 1,661 Issued 27,332 $ 32.73 $ 879 Vested ( 12,851 ) $ 30.40 $ ( 413 ) Forfeited - $ - $ - Nonvested at June 30, 2023 66,145 $ 32.65 $ 2,127

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 10. Fair Value Measurements Determination of Fair Value The Company follows ASC 820, “Fair Value Measurements and Disclosures,” to record fair value adjustments to certain assets and liabilities and to determine fair value disclosures. This codification clarifies that the fair value of a financial instrument is the price that would be received to sell an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. Fair value is best determined based upon quoted market prices. However, in many instances, there are no quoted market prices for the Company’s various financial instruments. In cases where quoted market prices are not available, fair values are based on estimates using present value or other valuation techniques. Those techniques are significantly affected by the assumptions used, including the discount rate and estimates of future cash flows. Accordingly, the fair value estimates may not be realized in an immediate settlement of the instrument. The fair value guidance provides a consistent definition of fair value, which focuses on exit price in the principal or most advantageous market for the asset or liability in an orderly transaction (that is, not a forced liquidation or distressed sale) between market participants at the measurement date under current market conditions. If there has been a significant decrease in the volume and level of activity for the asset or liability, a change in valuation technique or the use of multiple valuation techniques may be appropriate. In such instances, determining the price at which willing market participants would transact at the measurement date under current market conditions depends on the facts and circumstances and requires the use of significant judgment. The fair value is a reasonable point within the range that is most representative of fair value under current market conditions. Fair Value Hierarchy In accordance with this guidance, the Company groups its financial assets and financial liabilities generally measured at fair value in three levels, based on the markets in which the assets and liabilities are traded and the reliability of the assumptions used to determine fair value: Level 1 – Valuation is based on quoted prices in active markets for identical assets and liabilities. Level 2 – Valuation is based on observable inputs including quoted prices in active markets for similar assets and liabilities, quoted prices for identical or similar assets and liabilities in less active markets, and model-based valuation techniques for which significant assumptions can be derived primarily from or corroborated by observable data in the market. Level 3 – Valuation is based on model-based techniques that use one or more significant inputs or assumptions that are unobservable in the market The following describes the valuation techniques used by the Company to measure certain financial assets and liabilities recorded at fair value on a recurring basis in the consolidated financial statements: Securities available for sale Securities AFS are recorded at fair value on a recurring basis. Fair value measurement is based upon quoted market prices, when available (Level 1). If quoted market prices are not available, fair values are measured utilizing independent valuation techniques of identical or similar securities for which significant assumptions are derived primarily from or corroborated by observable market data. Third party vendors compile prices from various sources and may determine the fair value of identical or similar securities by using pricing models that consider observable market data (Level 2). Additional information on interest rate swaps is presented in Note 12 – Derivative Instruments and Hedging Activities. Interest rate swaps The Company recognizes interest rate swaps at fair value. The Company has contracted with a third-party to provide valuations for interest rate swaps using standard valuation techniques. The Company’s interest rate swaps are classified as Level 2. Additional information on interest rate swaps is presented in Note 12 – Derivative Instruments and Hedging Activities. The following tables present the balances measured at fair value on a recurring basis as of June 30, 2023 and December 31, 2022 (dollars in thousands): Fair Value Measurements at June 30, 2023 Using: Quoted Prices Significant Significant Description Balance (Level 1) (Level 2) (Level 3) Assets: U.S. Government treasuries $ 175,551 $ - $ 175,551 $ - U.S. Government agencies 38,839 - 38,839 - Mortgage-backed securities/CMOs 157,788 - 157,788 - Corporate bonds 18,702 - 18,702 - Municipal bonds 82,988 - 82,988 - Total securities available for sale $ 473,868 $ - $ 473,868 $ - Fair Value Measurements at December 31, 2022 Using: Quoted Prices Significant Significant Description Balance (Level 1) (Level 2) (Level 3) Assets: U.S. Government treasuries $ 242,470 $ - $ 242,470 $ - U.S. Government agencies 28,755 - 28,755 - Mortgage-backed securities/CMOs 167,076 - 167,076 - Corporate bonds 18,729 - 18,729 Municipal bonds 81,156 - 81,156 - Total securities available for sale $ 538,186 $ - $ 538,186 $ - Liabilities: Interest rate swap liabilities $ 506 $ - $ 506 $ - Total liabilities at fair value $ 538,692 $ - $ 538,692 $ - Certain financial assets are measured at fair value on a nonrecurring basis in accordance with GAAP. Adjustments to the fair value of these assets usually result from the application of lower-of-cost-or-market accounting or write downs of individual assets. The following describes the valuation techniques used by the Company to measure certain assets recorded at fair value on a nonrecurring basis in the consolidated financial statements: Collateral Dependent Loans with an ACL In accordance with ASC 326, we may determine that an individual loan exhibits unique risk characteristics which differentiate it from other loans within our loan pools. In such cases, the loans are evaluated for expected credit losses on an individual basis and excluded from the collective evaluation. Specific allocations of the ACL are determined by analyzing the borrower's ability to repay amounts owed, collateral deficiencies, the relative risk grade of the loan and economic conditions affecting the borrower's industry, among other things. A loan is considered to be collateral dependent when, based upon management's assessment, the borrower is experiencing financial difficulty and repayment is expected to be provided substantially through the operation or sale of the collateral. In such cases, expected credit losses are based on the fair value of the collateral at the measurement date, adjusted for estimated selling costs if satisfaction of the loan depends on the sale of the collateral. We reevaluate the fair value of collateral supporting collateral dependent loans on a quarterly basis. The fair value of real estate collateral supporting collateral dependent loans is evaluated by appraisal services using a methodology that is consistent with the Uniform Standards of Professional Appraisal Practice. The following table presents the Company's assets that were measured at fair value on a nonrecurring basis as of June 30, 2023 (dollars in thousands). There were no such assets to report as of December 31, 2022. Quoted Prices Significant Significant Description Balance (Level 1) (Level 2) (Level 3) Assets: Individually evaluated loans $ 461 $ - $ - $ 461 Description Fair Value Valuation Technique Unobservable Inputs Discount Rate Assets: Individually evaluated loans $ 461 Market comparables Discount applied to recent appraisal 20.0 % ASC 825, “Financial Instruments,” requires disclosures about fair value of financial instruments for interim periods and excludes certain financial instruments and all non-financial instruments from its disclosure requirements. Accordingly, the aggregate fair value amounts presented may not necessarily represent the underlying fair value of the Company. The Company uses the exit price notion in calculating the fair values of financial instruments not measured at fair value on a recurring basis. The carrying values and estimated fair values of the Company's financial instruments as of June 30, 2023 and December 31, 2022 are as follows (dollars in thousands): Fair Value Measurements at June 30, 2023 Using: Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Carrying value Level 1 Level 2 Level 3 Fair Value Assets Cash and cash equivalent $ 29,939 $ 29,939 $ - $ - $ 29,939 Available for sale securities 473,868 - 473,868 - 473,868 Restricted securities 7,438 - 7,438 - 7,438 Loans, net 965,485 - - 902,429 902,429 Bank owned life insurance 39,065 - 39,065 - 39,065 Accrued interest receivable 5,092 - 2,137 2,955 5,092 Liabilities Demand deposits and interest-bearing transaction and money market accounts $ 1,123,120 $ - $ 1,123,120 $ - $ 1,123,120 Certificates of deposit 224,956 - 224,677 - 224,677 Federal funds purchased 20,503 $ - 20,503 $ - 20,503 FHLB Borrowings 59,666 - 59,717 - 59,717 Junior subordinated debt, net 3,436 - 3,436 - 3,436 Accrued interest payable 1,059 - 1,059 - 1,059 Fair Value Measurements at December 31, 2022 Using: Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Carrying value Level 1 Level 2 Level 3 Fair Value Assets Cash and cash equivalent $ 40,136 $ 40,136 $ - $ - $ 40,136 Available for sale securities 538,186 - 538,186 - 538,186 Restricted securities 5,137 - 5,137 - 5,137 Loans, net 930,863 - - 890,929 890,929 Assets held for sale 965 - 965 - 965 Bank owned life insurance 38,552 - 38,552 - 38,552 Accrued interest receivable 4,879 - 2,265 2,614 4,879 Interest rate swap asset 506 - 506 - 506 Liabilities Demand deposits and interest-bearing transaction and money market accounts $ 1,363,232 $ - $ 1,363,232 $ - $ 1,363,232 Certificates of deposit 115,106 - 109,260 - 109,260 Junior subordinated debt, net 3,413 - 3,413 - 3,413 Accrued interest payable 157 - 157 - 157 The Company assumes interest rate risk (the risk that general interest rate levels will change) as a result of its normal operations. Consequently, the fair values of the Company’s financial instruments will fluctuate when interest rate levels change, and that change may be either favorable or unfavorable to the Company. Management attempts to match maturities of assets and liabilities to the extent believed necessary to minimize interest rate risk; however, borrowers with fixed rate obligations are less likely to prepay in a rising rate environment and more likely to prepay in a falling rate environment. Conversely, depositors who are receiving fixed rates are more likely to withdraw funds before maturity in a rising rate environment and less likely to do so in a falling rate environment. Management monitors rates and maturities of assets and liabilities and attempts to minimize interest rate risk by adjusting terms of new loans and deposits and by investing in securities with terms that mitigate the Company’s overall interest rate risk.

Other Comprehensive Income (Los

Other Comprehensive Income (Loss)	6 Months Ended
	Jun. 30, 2023
Other Comprehensive Income (Loss), Tax [Abstract]
Other Comprehensive Income (Loss)	Note 11. Other Comprehensive Income (Loss) The following table presents the changes in each component of accumulated other comprehensive income (loss) as of June 30, 2023 and June 30, 2022 (dollars in thousands). AFS Securities Interest Rate Swap Total Accumulated other comprehensive income (loss) at December 31, 2022 $ ( 49,024 ) $ 400 $ ( 48,624 ) Other comprehensive income (loss) arising during the period 3,647 ( 46 ) 3,601 Related income tax effects ( 766 ) 9 ( 757 ) 2,881 ( 37 ) 2,844 Reclassification into net income 206 ( 460 ) ( 254 ) Related income tax effects ( 43 ) 97 54 163 ( 363 ) ( 200 ) Accumulated other comprehensive loss at June 30, 2023 $ ( 45,980 ) $ — $ ( 45,980 ) AFS Securities Interest Rate Swap Total Accumulated other comprehensive loss at December 31, 2021 $ ( 2,164 ) $ ( 47 ) $ ( 2,211 ) Other comprehensive income (loss) arising during the period ( 45,415 ) 499 ( 44,916 ) Related income tax effects 9,536 ( 104 ) 9,432 ( 35,879 ) 395 ( 35,484 ) Accumulated other comprehensive income (loss) at June 30, 2022 $ ( 38,043 ) $ 348 $ ( 37,695 )

Derivatives Instruments and Hed

Derivatives Instruments and Hedging Activities	6 Months Ended
	Jun. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives Instruments and Hedging Activities	Note 12. Derivative Instruments and Hedging Activities The Company uses derivative financial instruments primarily to manage risks to the Company associated with changing interest rates, and to assist customers with their risk management objectives. The Company designates certain interest rate swaps as hedging instruments in qualifying cash flow hedges. The changes in fair value of these designated hedging instruments is reported as a component of other comprehensive income. Customer accommodation loan swaps are derivative contracts that are not designated in a qualifying hedging relationship. ​ Cash flow hedges . The Company designates interest rate swaps as cash flow hedges when they are used to manage exposure to variability in cash flows on variable rate borrowings such as the Company’s junior subordinated debt. These interest rate swaps are derivative financial instruments that manage the risk of variability in cash flows by exchanging variable-rate interest payments on a notional amount of the Company’s borrowings for fixed-rate interest payments. Interest rate swaps designated as cash flow hedges are expected to be highly effective in offsetting the effect of changes in interest rates on the amount of variable-rate interest payments, and the Company assesses the effectiveness of each hedging relationship quarterly. If the Company determines that a cash flow hedge is no longer highly effective, future changes in the fair value of the hedging instrument would be reported in earnings. At December 31, 2022 , the Company had a designated cash flow hedge to manage its exposure to variability in cash flows on one variable rate borrowing through 2036. In anticipation of terminating the borrowing position, such hedge position was liquidated in the first quarter of 2023 for a gain of $ 479 thousand. There are no other hedges in place as of June 30, 2023. Unrealized gains or losses recorded in other comprehensive income (loss) related to cash flow hedges are reclassified into earnings in the same period(s) during which the hedged interest payments affect earnings. When a designated hedging instrument is terminated and the hedged interest payments remain probable of occurring, any remaining unrecognized gain or loss in other comprehensive income is reclassified into earnings in the period(s) during which the forecasted interest payments affect earnings. Amounts reclassified into earnings and interest receivable or payable under designated interest rate swaps are reported in interest expense. The Company does not expect any unrealized losses related to cash flow hedges to be reclassified into earnings in the next twelve months. Cash collateral held at other banks for swaps was $ 580 thousand as of December 31, 2022. Related to the liquidation of the hedge as noted above, the cash collateral was returned to the Company. Collateral was dependent on the market valuation of the underlying hedges. The follow table summarizes the Company’s deriva tive instruments as of December 31, 2022 (dollars in thousands): December 31, 2022 Derivatives designated as hedging instruments Notional/ Contract Amount Fair Value Fair Value Balance Sheet Location Expiration Date Interest rate forward swap - cash flow $ 4,000 $ 506 Junior subordinated debt 6/15/2031

Segment Reporting

Segment Reporting	6 Months Ended
	Jun. 30, 2023
Segment Reporting [Abstract]
Segment Reporting	Note 13. Segment Reporting For the financial periods noted in this report, the Company has four reportable segments. Each reportable segment is a strategic business unit that offers different products and services. They are managed separately, because each segment appeals to different markets and, accordingly, require different technology and marketing strategies. The accounting policies of the segments are the same as those described in the summary of significant accounting policies provided earlier in this report. The four reportable segments are: • Bank - The commercial banking segment involves making loans and generating deposits from individuals, businesses and charitable organizations. Loan fee income, service charges from deposit accounts, and other non-interest-related fees, such as fees for debit cards and ATM usage and fees for treasury management services, generate additional income for the Bank segment. • Sturman Wealth Advisors – Sturman Wealth Advisors, formerly known as VNB Investment Services, offered wealth management and investment advisory services. Revenue for this segment was generated primarily from investment advisory and financial planning fees, with a small portion attributable to brokerage commissions. The Bank sold this business line effective December 19, 2022. • VNB Trust & Estate Services – VNB Trust & Estate Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. Revenue for this segment is generated from administration, service and custody fees, as well as management fees that are derived from Assets Under Management. Investment management services currently are offered through in-house and third-party managers. • Masonry Capital - Masonry Capital offers investment management services for separately managed accounts and a private investment fund employing a value-based, catalyst-driven investment strategy. Revenue for this segment is generated from management fees that are derived from Assets Under Management and incentive income that is based on the investment returns generated on performance-based Assets Under Management. Segment information for the three and six months ended June 30, 2023 and 2022 is shown in the following tables (dollars in thousands). Note that asset information is not reported below, as the assets of VNB Trust & Estate Services are reported at the Bank level and the assets of Sturman Wealth Advisors were reported at the Bank level prior to the sale of the business line on December 19, 2022; also, assets specifically allocated to the lines of business other than the Bank are insignificant and are no longer provided to the chief operating decision maker. Three months ended June 30, 2023 Bank VNB Trust & Masonry Consolidated Net interest income $ 13,703 $ - $ - $ 13,703 Provision for credit losses 261 - - 261 Noninterest income 1,637 250 158 2,045 Noninterest expense 7,987 361 216 8,564 Income (loss) before income taxes 7,092 ( 111 ) ( 58 ) 6,923 Provision for (benefit from) income 1,308 ( 24 ) ( 12 ) 1,272 Net income (loss) $ 5,784 $ ( 87 ) $ ( 46 ) $ 5,651 Six months ended June 30, 2023 Bank VNB Trust & Masonry Consolidated Net interest income $ 27,116 $ - $ - $ 27,116 Provision for credit losses 13 - - 13 Noninterest income 3,492 510 319 4,321 Noninterest expense 16,355 672 398 17,425 Income (loss) before income taxes 14,240 ( 162 ) ( 79 ) 13,999 Provision for (benefit from) income taxes 2,607 ( 34 ) ( 16 ) 2,557 Net income (loss) $ 11,633 $ ( 128 ) $ ( 63 ) $ 11,442 Three months ended June 30, 2022 Bank Sturman Wealth Advisors VNB Trust & Masonry Consolidated Net interest income $ 12,461 $ - $ - $ - $ 12,461 Provision for (recovery of) credit losses ( 217 ) - - - ( 217 ) Noninterest income 2,851 210 365 220 3,646 Noninterest expense 8,717 161 376 188 9,442 Income (loss) before income taxes 6,812 49 ( 11 ) 32 6,882 Provision for (benefit from) income 1,181 11 ( 2 ) 7 1,197 Net income (loss) $ 5,631 $ 38 $ ( 9 ) $ 25 $ 5,685 Six months ended June 30, 2022 Bank Sturman Wealth Advisors VNB Trust & Masonry Consolidated Net interest income $ 23,886 $ - $ - $ - $ 23,886 Provision for (recovery of) credit losses ( 69 ) - - - ( 69 ) Noninterest income 4,385 426 3,196 426 8,433 Noninterest expense 17,538 327 1,298 374 19,537 Income before income taxes 10,802 99 1,898 52 12,851 Provision for income taxes 1,811 21 399 11 2,242 Net income $ 8,991 $ 78 $ 1,499 $ 41 $ 10,609

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation: The unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information. Accordingly, the unaudited consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. The statements should be read in conjunction with the Notes to Consolidated Financial Statements included in the Company’s Form 10-K for the year ended December 31, 2022 .
Nature of Operations	Nature of Operations: The accompanying unaudited consolidated financial statements include the accounts of the Company, and its subsidiaries Virginia National Bank and Masonry Capital Management, LLC, a registered investment advisor. The Bank offers a full range of banking and related financial services to meet the needs of individuals, businesses and charitable organizations, including the fiduciary services of VNB Trust and Estate Services. Until the sale of the business line on December 19, 2022, the Bank also offered, through networking agreements with third parties, investment advisory and other investment services under Sturman Wealth Advisors. All significant intercompany balances and transactions have been eliminated in consolidation.
Basis of Presentation	Basis of Presentation: The preparation of financial statements in conformity with GAAP and the reporting guidelines prescribed by regulatory authorities requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term relate to the determination of the ACL, accounting for business combinations, including loans acquired in the business combination, ACL on individually evaluated loans, goodwill impairment, credit losses of securities, other intangible assets, and fair value measurements. Operating results for the three and six months ended June 30, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023 .
Reclassifications	Reclassifications: If needed, certain previously reported amounts have been reclassified to conform to current period presentation. No such reclassifications were significant.
Recent Significant Accounting Pronouncements and Adoption of New Accounting Standards	Recent Significant Accounting Pronouncements Financial Statement Presentation - In July 2023, the FASB issued ASU 2023-03, “Presentation of Financial Statements (Topic 205), Income Statement—Reporting Comprehensive Income (Topic 220), Distinguishing Liabilities from Equity (Topic 480), Equity (Topic 505), and Compensation—Stock Compensation (Topic 718)”. This ASU amends the FASB Accounting Standards Codification for SEC paragraphs pursuant to SEC Staff Accounting Bulletin No. 120, SEC Staff Announcement at the March 24, 2022 Emerging Issues Task Force Meeting, and Staff Accounting Bulletin Topic 6.B, Accounting Series Release 280—General Revision of Regulation S-X: Income or Loss Applicable to Common Stock. ASU 2023-03 is effective upon addition to the FASB Codification. The Company does not expect the adoption of ASU 2023-03 to have a material impact on its consolidated financial statements. Investments in Tax Credit Structures - In March 2023, the FASB issued ASU 2023-02, “Investments—Equity Method and Joint Ventures (Topic 323): Accounting for Investments in Tax Credit Structures Using the Proportional Amortization Method”. These amendments allow reporting entities to elect to account for qualifying tax equity investments using the proportional amortization method, regardless of the program giving rise to the related income tax credits. The ASU is effective for public business entities for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted for all entities in any interim period. The Company does not expect the adoption of ASU 2023-02 to have a material impact on its consolidated financial statements. LIBOR and Other Reference Rates - In December 2022, the FASB issued ASU 2022-06, “Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848”. ASU 2022-06 extends the period of time preparers can utilize the reference rate reform relief guidance in Topic 848. The objective of the guidance in Topic 848 is to provide relief during the temporary transition period, so the FASB included a sunset provision within Topic 848 based on expectations of when the LIBOR would cease being published. In 2021, the UK Financial Conduct Authority (FCA) delayed the intended cessation date of certain tenors of USD LIBOR to June 30, 2023. To ensure the relief in Topic 848 covers the period of time during which a significant number of modifications may take place, the ASU defers the sunset date of Topic 848 from December 31, 2022, to December 31, 2024, after which entities will no longer be permitted to apply the relief in Topic 848. The ASU is effective for all entities upon issuance. In March 2020, the FASB issued ASU No. 2020-04 “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” These amendments provide temporary optional guidance to ease the potential burden in accounting for reference rate reform. The ASU provides optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. It is intended to help stakeholders during the global market-wide reference rate transition period. The guidance is effective for all entities as of March 12, 2020 through December 31, 2022. Subsequently, in January 2021, the FASB issued ASU No. 2021-01 “Reference Rate Reform (Topic 848): Scope.” This ASU clarifies that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition. The ASU also amends the expedients and exceptions in Topic 848 to capture the incremental consequences of the scope clarification and to tailor the existing guidance to derivative instruments affected by the discounting transition. An entity may elect to apply ASU No. 2021-01 on contract modifications that change the interest rate used for margining, discounting, or contract price alignment retrospectively as of any date from the beginning of the interim period that includes March 12, 2020, or prospectively to new modifications from any date within the interim period that includes or is subsequent to January 7, 2021, up to the date that financial statements are available to be issued. An entity may elect to apply ASU No. 2021-01 to eligible hedging relationships existing as of the beginning of the interim period that includes March 12, 2020, and to new eligible hedging relationships entered into after the beginning of the interim period that includes March 12, 2020. The Company has identified all loans that are directly or indirectly impacted by LIBOR. Other accounting standards that have been issued by the FASB or other standards-setting bodies are not currently expected to have a material effect on the Company's financial position, results of operations or cash flows. Adoption of New Accounting Standards Financial Instruments – Credit Losses - On January 1, 2023, the Company adopted ASU 2016-13, “Financial Instruments – Credit Losses: Measurement of Credit Losses on Financial Instruments," and ASU 2022-02, “Financial Instruments-Credit Losses, Troubled Debt Restructurings and Vintage Disclosures,” collectively referred to as ASC 326. This standard, in part, replaced the incurred loss methodology with an expected loss methodology that is referred to as the current expected credit loss ("CECL") methodology. ASC 326 requires an estimate of credit losses for the remaining estimated life of the financial assets using historical experience, current conditions, and reasonable and supportable forecasts and generally applies to financial assets measured at amortized cost, including loan receivables and held-to-maturity debt securities, and some off-balance sheet credit exposures such as unfunded commitments to extend credit. Financial assets measured at amortized cost will be presented at the net amount expected to be collected by using an allowance for credit losses. Purchased credit deteriorated loans will receive an initial allowance at the acquisition date that represents an adjustment to the amortized cost basis of the loan, with no impact to earnings. In addition, ASU 326 made changes to the accounting for available-for-sale debt securities. One change is to require credit losses to be presented as an allowance rather than as a write-down on available for sale debt securities if management does not intend to sell and does not believe that it is more likely than not, they will be required to sell. The Company adopted ASC 326 and all related subsequent amendments thereto effective January 1, 2023 using the modified retrospective approach for all financial assets measured at amortized cost and off-balance sheet credit exposures. The transition adjustment of the adoption included an increase in the ACL on loans of $ 2.5 million, which is presented as a reduction to net loans outstanding, and an increase in the ACL for unfunded loan commitments of $ 252 thousand, which is recorded within Accrued interest payable and other liabilities on the consolidated balance sheets. The Company recorded a net decrease to opening retained earnings as of January 1, 2023 of $ 1.9 million, for the cumulative effect of adopting ASC 326, which reflects the transition adjustments noted above, net of the applicable deferred tax assets recorded. Results for reporting periods beginning after January 1, 2023 are presented under ASC 326 while prior period amounts continue to be reported in accordance with previously applicable accounting standards ("Incurred Loss"). Subsequent to adoption, the Company will record adjustments to its ACL and reserve for unfunded commitments through the provision for credit losses in the consolidated statements of income. ASC 326 also replaced the Company's previous accounting policies for PCI loans and TDRs. With the adoption of ASC 326, loans previously designated as PCI loans were designated as purchased loans with credit deterioration (PCD loans). The Company adopted ASC 326 using the prospective transition approach for PCD loans that were previously identified as PCI and accounted for under ASC 310-30. On January 1, 2023, the Company's PCD loans were adjusted to reflect the addition of $ 355 thousand of expected credit losses to the amortized cost basis of the loans and a corresponding increase to the ACL. The remaining noncredit discount, the difference between the adjusted amortized cost basis and the outstanding principal balance on PCD loans, will be accreted into interest income over the estimated remaining lives of the loans using the effective interest rate method. The evaluation of the ACL will include PCD loans together with other loans that share similar risk characteristics, rather than using the separate pools that were used under PCI accounting. The adoption of ASC 326 also replaced previous TDR accounting guidance, and the evaluation of the ACL will include loans previously designated as TDRs together with other loans that share similar risk characteristics. The adoption of ASC 326 did not affect the carrying value of debt securities or the amount of unrealized gains and losses recorded in accumulated other comprehensive loss. Upon adoption of ASC 326, the Company did not have any securities included in its portfolio where OTTI had previously been recognized or that required an ACL. Therefore, the Company determined that an ACL on AFS securities was not deemed material. The following table illustrates the impact of adopting ASC 326 (dollars in thousands): December 31, 2022 January 1, 2023 January 1, 2023 As Previously Reported Impact of As Reported Under ASC 326 Assets: Loans, gross $ 936,415 $ 355 $ 936,770 Allowance for credit losses: Commercial 194 ( 11 ) 183 Real estate construction and land 221 440 661 1-4 family residential mortgages 1,618 14 1,632 Commercial mortgages 2,820 1,577 4,397 Consumer 699 471 1,171 Allowance for credit losses $ 5,552 $ 2,491 $ 8,044 Loans, net $ 930,863 $ ( 2,136 ) $ 928,726 Net deferred tax asset $ 17,315 $ 499 $ 17,814 Liabilities: Reserve for credit losses on unfunded commitments 60 253 313 Total equity $ 133,416 $ ( 1,890 ) $ 131,526 Available for Sale Securities - For AFS securities, management evaluates all investments in an unrealized loss position on a quarterly basis, and more frequently when economic or market conditions warrant such evaluation. If the Company has the intent to sell the security or it is more likely than not that the Company will be required to sell the security, the security is written down to fair value and the entire loss is recorded in earnings. If either of the above criteria is not met, the Company evaluates whether the decline in fair value is the result of credit losses or other factors. In making the assessment, the Company may consider various factors including the extent to which fair value is less than amortized cost, performance on any underlying collateral, downgrades in the ratings of the security by a rating agency, the failure of the issuer to make scheduled interest or principal payments and adverse conditions specifically related to the security. If the assessment indicates that a credit loss exists, the present value of cash flows expected to be collected are compared to the amortized cost basis of the security and any excess is recorded as an ACL, limited by the amount that the fair value is less than the amortized cost basis. Any amount of unrealized loss that has not been recorded through an ACL is recognized in other comprehensive income. Changes in the ACL are recorded as provision for (or reversal of) credit loss expense. Losses are charged against the ACL when management believes an AFS security is confirmed to be uncollectible or when either of the criteria regarding intent or requirement to sell is met. At June 30, 2023, there was no ACL related to the AFS securities portfolio. Loans - Loans that management has the intent and ability to hold for the foreseeable future or until maturity or payoff are reported at amortized cost. Amortized cost is the principal balance outstanding, net of purchase premiums and discounts and deferred fees and costs. Accrued interest receivable related to loans totaled $ 2.9 million at June 30, 2023 and was reported in Accrued interest receivable and other assets on the consolidated balance sheets. Interest income is accrued on the unpaid principal balance. Loan origination fees, net of certain direct origination costs, are deferred and recognized in interest income using methods that approximate a level yield without anticipating prepayments. The accrual of interest is generally discontinued when a loan becomes 90 days past due and is not well collateralized and in the process of collection, or when management believes, after considering economic and business conditions and collection efforts, that the principal or interest will not be collectible in the normal course of business. Past due status is based on contractual terms of the loan. A loan is considered to be past due when a scheduled payment has not been received 30 days after the contractual due date. All accrued interest is reversed against interest income when a loan is placed on nonaccrual status. Interest received on such loans is accounted for using the cost-recovery method, until qualifying for return to accrual. Under the cost-recovery method, interest income is not recognized until the loan balance is reduced to zero. Loans are returned to accrual status when all the principal and interest amounts contractually due are brought current, there is a sustained period of repayment performance, and future payments are reasonably assured. Allowance for Credit Losses - Purchased Credit Deteriorated Loans - Upon adoption of ASC 326, loans that were designated as PCI loans under the previous accounting guidance were classified as PCD loans without reassessment. In future acquisitions, the Company may purchase loans, some of which may have experienced more than insignificant credit deterioration since origination. In those cases, the Company will consider internal loan grades, delinquency status and other relevant factors in assessing whether purchased loans are PCD. PCD loans are recorded at the amount paid. An initial ACL is determined using the same methodology as other loans held for investment, but with no impact to earnings. The initial ACL determined on a collective basis is allocated to individual loans. The sum of the loan's purchase price and ACL becomes its initial amortized cost basis. The difference between the initial amortized cost basis and the par value of the loan is a noncredit discount or premium, which is amortized into interest income over the life of the loan. Subsequent to initial recognition, PCD loans are subject to the same interest income recognition and impairment model as non-PCD loans, with changes to the ACL recorded through provision expense. Allowance for Credit Losses - Loans - The ACL is a valuation account that is deducted from the loans' amortized cost basis to present the net amount expected to be collected on the loans. Loans are charged off against the allowance when management believes the uncollectibility of a loan balance is confirmed. Expected recoveries do not exceed the aggregate of amounts previously charged-off and expected to be charged-off. Accrued interest receivable is excluded from the estimate of credit losses. The ACL represents management’s estimate of lifetime credit losses inherent in loans as of the balance sheet date. The ACL is estimated by management using relevant available information, from both internal and external sources, relating to past events, current conditions, and reasonable and supportable forecasts. The Company measures expected credit losses for loans on a pooled basis when similar risk characteristics exist. The Company has identified ten portfolio segments and calculates the ACL for each using the methodology specified below (with the major classification noted in italics) : Discounted cash flow methodology: 1. Commercial and industrial (Commercial) 2. Construction (Real estate construction and land) 3. Consumer (Consumer) 4. Commercial real estate, non-owner occupied (Commercial mortgage) 5. Commercial real estate, owner occupied (Commercial mortgage) 6. Home equity and junior liens (1-4 family residential mortgage) 7. Multifamily (Commercial mortgage) 8. Residential first lien (1-4 family residential mortgage) Remaining life methodology: 9. Minute lender (Consumer/Commercial) 10. Student loans (Consumer) Additionally, the ACL calculation includes subjective adjustments for qualitative risk factors that are likely to cause estimated credit losses to differ from historical experience. These qualitative adjustments may increase reserve levels and include: adjustments for changes in lending policies and procedures and underwriting practices; changes in national, regional and local economic conditions; changes in the nature and volume of the portfolio and terms of loans; changes in the experience, depth and ability of credit and loan operations staff; changes in the volume and severity of past due, special mention and substandard loans; changes in the quality of the loan review system; changes in the value of underlying collateral for loans that are not collateral dependent; the existence and effect of any concentrations of credit and changes in the levels of such concentrations, and the effect of other external factors such as competition, legal and regulatory requirements, on the level of estimated credit losses. Loans that do not share risk characteristics are evaluated on an individual basis and are not included in the collective analysis. The ACL on loans that are individually evaluated may be estimated based on their expected cash flows, or, in the case of loans for which repayment is expected substantially through the sale of collateral, the expected credit losses are based on the fair value of collateral at the reporting dated adjusted for selling costs as appropriate. Allowance for Credit Losses – Reserve for Unfunded Commitments - The Company records an ACL for off-balance sheet credit exposures, unless the commitments to extend credit are unconditionally cancelable, through a charge to provision for credit losses in the Company’s consolidated statements of income. The ACL for off-balance sheet credit exposures is estimated by loan segment at each balance sheet date under the current expected credit loss model using the same methodologies as portfolio loans, taking into consideration the likelihood that funding will occur as well as any third-party guarantees. The allowance for unfunded commitments is included in Accrued interest and other liabilities on the Company’s consolidated balance sheets. Accrued Interest Receivable - The Company elected not to measure an ACL for accrued interest receivable and instead elected to reverse interest income on loans or securities that are placed on nonaccrual status, which is generally when the instrument is 90 days past due, or earlier if the Company believes the collection of interest is doubtful. The Company has concluded that this policy results in the timely reversal of uncollectible interest.

Adoption of New Accounting St_2

Adoption of New Accounting Standards (Tables)	6 Months Ended
	Jun. 30, 2023
Accounting Changes and Error Corrections [Abstract]
Schedule of Impact of Adopting ASC 326	The following table illustrates the impact of adopting ASC 326 (dollars in thousands): December 31, 2022 January 1, 2023 January 1, 2023 As Previously Reported Impact of As Reported Under ASC 326 Assets: Loans, gross $ 936,415 $ 355 $ 936,770 Allowance for credit losses: Commercial 194 ( 11 ) 183 Real estate construction and land 221 440 661 1-4 family residential mortgages 1,618 14 1,632 Commercial mortgages 2,820 1,577 4,397 Consumer 699 471 1,171 Allowance for credit losses $ 5,552 $ 2,491 $ 8,044 Loans, net $ 930,863 $ ( 2,136 ) $ 928,726 Net deferred tax asset $ 17,315 $ 499 $ 17,814 Liabilities: Reserve for credit losses on unfunded commitments 60 253 313 Total equity $ 133,416 $ ( 1,890 ) $ 131,526

Securities (Tables)

Securities (Tables)	6 Months Ended
	Jun. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Schedule of Amortized Cost and Fair Values of Securities Available For Sale	The amortized cost and fair values of securities available for sale as of June 30, 2023 and December 31, 2022 were as follows (dollars in thousands): June 30, 2023 Gross Gross Amortized Unrealized Unrealized Fair Cost Gains (Losses) Value U.S. Government treasuries $ 177,277 $ - $ ( 1,726 ) $ 175,551 U.S. Government agencies 45,179 - ( 6,340 ) 38,839 Mortgage-backed securities/CMOs 185,436 - ( 27,648 ) 157,788 Corporate bonds 19,630 - ( 928 ) 18,702 Municipal bonds 104,550 - ( 21,562 ) 82,988 Total Securities Available for Sale $ 532,072 $ - $ ( 58,204 ) $ 473,868 December 31, 2022 Gross Gross Amortized Unrealized Unrealized Fair Cost Gains (Losses) Value U.S. Government treasuries $ 245,583 $ - $ ( 3,113 ) $ 242,470 U.S. Government agencies 35,283 - ( 6,528 ) 28,755 Mortgage-backed securities/CMOs 194,964 - ( 27,888 ) 167,076 Corporate bonds 19,581 - ( 852 ) 18,729 Municipal bonds 104,831 - ( 23,675 ) 81,156 Total Securities Available for Sale $ 600,242 $ - $ ( 62,056 ) $ 538,186
Schedule of Unrealized Losses in the Bank's Securities Portfolio	The following table summarizes all securities with unrealized losses, segregated by length of time in a continuous unrealized loss position, for which no allowance for credit losses was recorded, at June 30, 2023, and December 31, 2022 (dollars in thousands): Less than 12 Months 12 Months or More Total June 30, 2023 Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses U.S. Government treasuries $ 84,250 $ ( 238 ) $ 91,301 $ ( 1,488 ) $ 175,551 $ ( 1,726 ) U.S. Government agencies 10,107 ( 53 ) 28,731 ( 6,287 ) 38,838 ( 6,340 ) Mortgage-backed/CMOs 13,028 ( 730 ) 144,760 ( 26,918 ) 157,788 ( 27,648 ) Corporate bonds 9,628 ( 403 ) 9,075 ( 525 ) 18,703 ( 928 ) Municipal bonds 3,123 ( 102 ) 77,843 ( 21,460 ) 80,966 ( 21,562 ) $ 120,136 $ ( 1,526 ) $ 351,710 $ ( 56,678 ) $ 471,846 $ ( 58,204 ) Less than 12 Months 12 Months or More Total December 31, 2022 Fair Unrealized Fair Unrealized Fair Unrealized Value Losses Value Losses Value Losses U.S. Government treasuries $ 242,470 $ ( 3,113 ) $ - $ - $ 242,470 $ ( 3,113 ) U.S. Government agencies 4,285 ( 620 ) 24,218 ( 5,908 ) 28,503 ( 6,528 ) Mortgage-backed/CMOs 55,396 ( 6,010 ) 111,689 ( 21,878 ) 167,085 ( 27,888 ) Corporate bonds 18,729 ( 852 ) - - 18,729 ( 852 ) Municipal bonds 44,117 ( 8,001 ) 35,964 ( 15,674 ) 80,081 ( 23,675 ) $ 364,997 $ ( 18,596 ) $ 171,871 $ ( 43,460 ) $ 536,868 $ ( 62,056 )
Schedule of Amortized Cost and Fair Values of Securities Available For Sale Based upon Contractual Maturities and by Major Investment Categories	The amortized cost and fair value of AFS debt securities at June 30, 2023 are presented below based upon contractual maturities, by major investment categories (dollars in thousands). Expected maturities may differ from contractual maturities because issuers have the right to call or prepay obligations. Amortized Cost Fair Value U.S. Government treasuries One year or less $ 165,818 $ 164,439 After one year to five years 11,459 11,112 $ 177,277 $ 175,551 U.S. Government agencies One year or less $ 10,000 $ 9,948 After one year to five years 5,802 5,049 After five years to ten years 25,377 20,918 Ten years or more 4,000 2,924 $ 45,179 $ 38,839 Mortgage-backed securities/CMOs One year or less $ 2,954 $ 2,890 After one year to five years 6,452 6,051 After five years to ten years 3,185 2,878 Ten years or more 172,845 145,969 $ 185,436 $ 157,788 Corporate bonds One year or less $ 1,002 $ 977 After one year to five years 18,628 17,725 $ 19,630 $ 18,702 Municipal bonds After one year to five years $ 3,060 $ 2,922 After five years to ten years 19,892 18,089 Ten years or more 81,598 61,977 $ 104,550 $ 82,988 Total Debt Securities Available for Sale $ 532,072 $ 473,868

Loans (Tables)

Loans (Tables)	6 Months Ended
	Jun. 30, 2023
Loans and Leases Receivable Disclosure [Abstract]
Schedule of Composition of Loan Portfolio by Major Loan Classifications	The composition of the loan portfolio by major loan classifications at June 30, 2023 and December 31, 2022 , stated at their face amount, net of deferred fees and costs and discounts, including fair value marks, appears below (dollars in thousands). The Company has elected to exclude accrued interest receivable, totaling $ 2.9 million as of June 30, 2023, from the amortized cost basis of loans. June 30, December 31, 2023 2022 Commercial $ 98,312 $ 71,139 Real estate construction and land 29,825 37,541 1-4 family residential mortgages 317,330 323,185 Commercial mortgages 486,643 459,125 Consumer 41,238 45,425 Total loans 973,348 936,415 Less: Allowance for credit losses ( 7,863 ) ( 5,552 ) Net loans $ 965,485 $ 930,863
Summary of Outstanding Principal Balance and Carrying Amount of Loans Acquired in Business Combination	(dollars in thousands): December 31, 2022 Acquired Loans - Acquired Loans - Purchased Performing Acquired Outstanding principal balance $ 43,250 $ 290,604 $ 333,854 Carrying amount: Commercial $ 630 $ 12,606 $ 13,236 Real estate construction and land 1,461 8,530 9,991 1-4 family residential mortgages 9,076 164,280 173,356 Commercial mortgages 20,828 99,206 120,034 Consumer 72 1,277 1,349 Total acquired loans $ 32,067 $ 285,899 $ 317,966
Summary of Changes in Accretable Yield of Loans Classified as Purchased Credit Impaired	The following table presents a summary of the changes in the accretable yield of loans classified as purchased credit impaired (dollars in thousands): Three Months Ended June 30, Six Months Ended June 30, 2022 2022 Accretable yield, beginning of period 12,428 13,742 Accretion ( 761 ) ( 1,500 ) Reclassification from nonaccretable difference - 2,193 Other changes, net - ( 2,768 ) Accretable yield, end of period 11,667 11,667
Schedule of Aging of Past Due Loans	The following table shows the aging of the Company's loan portfolio, by class, at June 30, 2023 (dollars in thousands): 30-59 Days 60-89 Days 90 Days or More Past Due and Still Accruing Nonaccrual Loans Current Loans Total Loans Commercial $ 793 $ - $ - $ - $ 97,519 $ 98,312 Real estate construction and land - - - - 29,825 29,825 1-4 family residential mortgages 292 59 - 713 316,266 317,330 Commercial mortgages 439 - - 472 485,732 486,643 Consumer loans 264 1 107 - 40,866 41,238 Total Loans $ 1,788 $ 60 $ 107 $ 1,185 $ 970,208 $ 973,348 The past due status of loans as of December 31, 2022 was as follows (dollars in thousands): 30-59 Days 60-89 Days 90 Days or More Total PCI Current Total 90 Days Past Due and Still Accruing Commercial $ - $ 24 $ - $ 24 $ 630 $ 70,485 $ 71,139 $ - Real estate construction and land 287 - 75 362 1,461 35,718 37,541 - 1-4 family residential mortgages 1,176 191 598 1,965 9,076 312,144 323,185 - Commercial mortgages 330 - 646 976 20,828 437,321 459,125 646 Consumer loans 315 41 59 415 72 44,938 45,425 59 Total Loans $ 2,108 $ 256 $ 1,378 $ 3,742 $ 32,067 $ 900,606 $ 936,415 $ 705
Schedule of Impaired Loans Classified as Non-Accruals by Class	The following table shows the Company's amortized cost basis of loans on nonaccrual status as of June 30, 2023 and December 31, 2022 (dollars in thousands). CECL Incurred Loss June 30, 2023 December 31, 2022 Nonaccrual Loans with No Allowance Nonaccrual Loans with an Allowance Total Nonaccrual Loans Nonaccrual Loans Commercial $ - $ - $ - $ - Real estate construction and land - - - - 1-4 family residential mortgages 233 480 713 673 Commercial mortgages 472 472 - Consumer - - - - Total Loans $ 705 $ 480 $ 1,185 $ 673
Schedule of Loans Modified Under Terms of a TDR	The following table provides a summary, by class, of TDRs as of December 31, 2022 that continued to accrue interest under the terms of the restructuring agreement, which were considered to be performing, and TDRs that were placed in nonaccrual status which were considered to be nonperforming (dollars in thousands): Troubled debt restructurings December 31, 2022 No. of Recorded Loans Investment Performing TDRs 1-4 family residential mortgages 1 $ 88 Consumer 46 700 Total performing TDRs 47 $ 788 Nonperforming TDRs 1-4 family residential mortgages 2 $ 495 Consumer - - Total nonperforming TDRs 2 495 Total TDRs 49 $ 1,283

Allowance for Credit Losses (Ta

Allowance for Credit Losses (Tables)	6 Months Ended
	Jun. 30, 2023
Allowance For Loan Losses [Abstract]
Summary of Transactions in Allowance for Loan Losses by Major Loan Portfolio Segment	The following table shows the ACL activity by loan portfolio for the three and six months ended June 30, 2023 (dollars in thousands): Commercial Real Estate 1-4 family residential mortgages Commercial mortgages Consumer Total Allowance for Credit Losses: Balance as of December 31, 2022 $ 194 $ 221 $ 1,618 $ 2,820 $ 699 $ 5,552 Impact of ASC 326 adoption ( 11 ) 440 14 1,577 471 2,491 Charge-offs - - - - ( 142 ) ( 142 ) Recoveries - - 3 41 62 106 Provision for (recovery of) credit ( 7 ) ( 90 ) ( 75 ) 33 ( 96 ) ( 235 ) Balance as of March 31, 2023 $ 176 $ 571 $ 1,560 $ 4,471 $ 994 $ 7,772 Charge-offs - - - - ( 180 ) ( 180 ) Recoveries 20 - 2 - 33 55 Provision for (recovery of) credit 19 ( 107 ) 715 ( 516 ) 105 216 Balance as of June 30, 2023 $ 215 $ 464 $ 2,277 $ 3,955 $ 952 $ 7,863 The following table presents the changes in the ACL by major classification during the year ended December 31, 2022 (dollars in thousands): Commercial Real Estate Real Estate Consumer Total Allowance for Credit Losses: Balance as of beginning of year $ 252 $ 399 $ 4,478 $ 855 $ 5,984 Charge-offs ( 600 ) - - ( 655 ) ( 1,255 ) Recoveries 519 9 11 178 717 Provision for (recovery of) loan losses 23 ( 187 ) ( 51 ) 321 106 Ending Balance $ 194 $ 221 $ 4,438 $ 699 $ 5,552 Ending Balance: Individually evaluated for impairment $ - $ - $ - $ 23 $ 23 Collectively evaluated for impairment 194 221 4,438 676 5,529 Acquired loans - purchased credit - - - - - Loans: Individually evaluated for impairment $ - $ - $ 583 $ 700 $ 1,283 Collectively evaluated for impairment 70,509 36,080 751,823 44,653 903,065 Acquired loans - purchased credit impaired 630 1,461 29,904 72 32,067 Ending Balance $ 71,139 $ 37,541 $ 782,310 $ 45,425 $ 936,415
Summary of Provision for Credit Losses	The following table presents a breakdown of the provision for credit losses for the periods indicated (dollars in thousands): Three Months Ended Six Months Ended June 30, 2023 June 30, 2022 June 30, 2023 June 30, 2022 Provision for credit losses: Provision (recovery) for loans $ 216 $ ( 217 ) $ ( 19 ) $ ( 69 ) Provision for unfunded commitments 45 - 32 - Total $ 261 $ ( 217 ) $ 13 $ ( 69 )
Summary of Amortized Cost Basis of Collateral Dependent Loans Individually Evaluated to Determine Expected Credit Losses, and Related ACL Allocated to Loans	The following table presents the Company's amortized cost basis of collateral dependent loans, which are individually evaluated to determine expected credit losses, and the related ACL allocated to those loans as of June 30, 2023 (dollars in thousands): June 30, 2023 Real Estate Secured Loans Allowance for Credit Losses -Loans Commercial real estate - non owner occupied $ 698 $ - Residential 1-4 family real estate 741 19 Total $ 1,439 $ 19
Summary of Credit Quality Indicators	The following table presents the Company's recorded investment in loans by credit quality indicators by year of origination as of June 30, 2023 (dollars in thousands). Current period gross write-off amounts represent write-offs for the six months ended June 30, 2023 (dollars in thousands): June 30, 2023 Term Loans Amortized Cost Basis by Origination Year 2023 2022 2021 2020 2019 Prior Revolving Loans Loans Converted to Term Total Commercial Pass $ 28,457 $ 12,818 $ 3,101 $ 5,959 $ 8,560 $ 15,005 $ 22,694 $ 14 $ 96,608 Watch - 44 - - 122 7 7 - 180 Special Mention - - 1 - - 93 215 - 309 Substandard - 73 10 40 344 261 - 487 1,215 Total commercial $ 28,457 $ 12,935 $ 3,112 $ 5,999 $ 9,026 $ 15,366 $ 22,916 $ 501 $ 98,312 Current period gross write-off $ - $ - $ - $ - $ - $ - $ - $ - $ - . Real estate construction and land Pass $ 3,665 $ 13,539 $ 4,512 $ 1,754 $ 940 $ 2,932 $ - $ - $ 27,342 Watch - - - - - 329 - - 329 Special Mention - - - - - 750 - - 750 Substandard - - - - 364 1,040 - - 1,404 Total real estate construction and land $ 3,665 $ 13,539 $ 4,512 $ 1,754 $ 1,304 $ 5,051 $ - $ - $ 29,825 Current period gross write-off $ - $ - $ - $ - $ - $ - $ - $ - $ - . 1-4 family residential mortgages Pass $ 9,025 $ 14,994 $ 57,925 $ 77,837 $ 25,810 $ 93,193 $ 23,425 $ 387 $ 302,596 Watch - 1,396 125 1,449 - 6,025 470 - 9,465 Special Mention - 853 127 - - 1,389 78 - 2,447 Substandard - - 55 507 99 2,161 - - 2,822 Total 1-4 family residential mortgage $ 9,025 $ 17,243 $ 58,232 $ 79,793 $ 25,909 $ 102,768 $ 23,973 $ 387 $ 317,330 Current period gross write-off $ - $ - $ - $ - $ - $ - $ - $ - $ - . Commercial mortgages Pass $ 48,144 $ 40,929 $ 48,145 $ 105,357 $ 36,869 $ 168,088 $ 2,518 $ - $ 450,050 Watch - - 265 178 7,311 13,216 - - 20,970 Special Mention - - 394 291 - 4,257 - - 4,942 Substandard 156 - 1,860 2,838 - 5,827 - - 10,681 Total commercial mortgages $ 48,300 $ 40,929 $ 50,664 $ 108,664 $ 44,180 $ 191,388 $ 2,518 $ - $ 486,643 Current period gross write-off $ - $ - $ - $ - $ - $ - $ - $ - $ - Consumer Pass $ 76 $ 237 $ 587 $ 412 $ 179 $ 24,303 $ 14,389 $ 40,183 Watch - - - 15 12 825 - 852 Special Mention - - - - - 75 1 9 85 Substandard - - 3 - 8 107 - 118 Total consumer $ 76 $ 237 $ 590 $ 427 $ 199 $ 25,310 $ 14,390 $ 9 $ 41,238 Current period gross write-off $ - $ - $ 17 $ 1 $ 27 $ 273 $ 4 $ - $ 322 The following represents the loan portfolio designated by the internal risk ratings assigned to each credit as of December 31, 2022 (dollars in thousands). There were no loans rated “Doubtful” as December 31, 2022. December 31, 2022 Excellent Good Pass Watch Special Sub- TOTAL Commercial $ 30,121 $ 16,058 $ 22,853 $ 992 $ 122 $ 993 $ 71,139 Real estate construction and land - - 35,258 342 532 1,409 $ 37,541 1-4 family residential mortgages - - 308,041 7,935 5,431 1,778 $ 323,185 Commercial mortgages - - 408,513 34,828 3,872 11,912 $ 459,125 Consumer 461 17,544 26,326 977 22 95 $ 45,425 Total Loans $ 30,582 $ 33,602 $ 800,991 $ 45,074 $ 9,979 $ 16,187 $ 936,415

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Gross Carrying Amounts and Accumulated Amortization of Other Intangible Assets	The following table summarizes the gross carrying amounts and accumulated amortization of other intangible assets (dollars in thousands): June 30, 2023 December 31, 2022 June 30, 2022 Gross Carrying Amount Accumulated Amortization Gross Carrying Amount Accumulated Amortization Gross Carrying Amount Accumulated Amortization Amortized intangible assets: Core deposit intangible $ 9,660 $ ( 3,845 ) $ 9,660 $ ( 3,074 ) $ 9,660 $ ( 2,255 ) Customer relationships intangible - - - - 773 ( 533 ) Total $ 9,660 $ ( 3,845 ) $ 9,660 $ ( 3,074 ) $ 10,433 $ ( 2,788 )
Schedule of Estimated Future Amortization Expense	Estimated future amortization expense as of June 30, 2023 is as follows (dollars in thousands): Core Deposit Intangible For the six months ending December 31, 2023 $ 722 For the year ending December 31, 2024 1,301 For the year ending December 31, 2025 1,110 For the year ending December 31, 2026 918 For the year ending December 31, 2027 726 Thereafter 1,038 Total $ 5,815

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jun. 30, 2023
Leases [Abstract]
Schedule of Lease Liability, Right-of-use Asset, Weighted Average Remaining Lease Term and Discount Rate	The following tables present information about the Company’s leases (dollars in thousands): June 30, 2023 June 30, 2022 Lease liability $ 6,301 $ 6,925 Right-of-use asset $ 6,634 $ 7,343 Weighted average remaining lease term 5.03 years 5.84 years Weighted average discount rate 2.07 % 1.97 %
Schedule of Operating Lease Expense	Three Months Ended June 30, Six Months Ended June 30, Lease Expense: 2023 2022 2023 2022 Operating lease expense $ 395 $ 449 $ 906 $ 894 Short-term lease expense 81 139 204 191 Total lease expense $ 476 $ 588 $ 1,110 $ 1,085 Cash paid for amounts included in $ 336 $ 418 $ 848 $ 832
Schedule of Operating Lease Liabilities and Reconciliation of Undiscounted Cash Flows	A maturity analysis of operating lease liabilities and reconciliation of the undiscounted cash flows to the total of operating lease liabilities is as follows (dollars in thousands): Undiscounted Cash Flow June 30, 2023 Six months ending December 31, 2023 $ 694 Twelve months ending December 31, 2024 1,332 Twelve months ending December 31, 2025 1,248 Twelve months ending December 31, 2026 907 Twelve months ending December 31, 2027 811 Thereafter 1,665 Total undiscounted cash flows $ 6,657 Less: Discount ( 356 ) Lease liability $ 6,301

Net Income Per Share (Tables)

Net Income Per Share (Tables)	6 Months Ended
	Jun. 30, 2023
Earnings Per Share [Abstract]
Schedule of weighted average number of shares used in computing earnings per share	The table below shows the weighted average number of shares used in computing net income per common share and the effect of the weighted average number of shares of potential dilutive common stock for the three and six months ended June 30, 2023 and 2022. Diluted net income per share is computed based on the weighted average number of shares of common stock equivalents outstanding, to the extent dilutive. The Company’s common stock equivalents relate to outstanding common stock options. The recipients of unvested restricted shares have full voting and dividend rights, and as such, unvested restricted stock as of June 30, 2023 and June 30, 2022 is included in the calculation of basic and diluted net income per share (dollars below reported in thousands except per share data). Three Months Ended June 30, 2023 June 30, 2022 Net Weighted Per Net Weighted Per Basic net income per share $ 5,651 5,357,873 $ 1.05 $ 5,685 5,326,271 $ 1.07 Effect of dilutive stock options - 17,200 - - 20,737 ( 0.01 ) Diluted net income per share $ 5,651 5,375,073 $ 1.05 $ 5,685 5,347,008 $ 1.06 Six Months Ended June 30, 2023 June 30, 2022 Net Weighted Per Net Weighted Per Basic net income per share $ 11,442 5,348,040 $ 2.14 $ 10,609 5,319,166 $ 1.99 Effect of dilutive stock options - 27,505 ( 0.01 ) - 26,076 ( 0.01 ) Diluted net income per share $ 11,442 $ 5,375,545 $ 2.13 $ 10,609 5,345,242 $ 1.98

Stock Incentive Plans (Tables)

Stock Incentive Plans (Tables)	6 Months Ended
	Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]
Summary of Shares Issued and Available Under Each Plans	A summary of the shares issued and available under each of the Plans is shown below as of June 30, 2023 . Share data and exercise price range per share have been adjusted to reflect prior issued stock dividends. Although the 2005 Plan has expired and no new grants will be issued under this plan, there were options issued before the plan expired that are still outstanding as shown below. 2022 Plan 2014 Plan 2005 Plan Aggregate shares issuable 150,000 275,625 253,575 Options issued, net of forfeited and expired - ( 173,706 ) ( 59,870 ) Unrestricted stock issued - ( 11,635 ) - Restricted stock grants issued, net of forfeited ( 18,932 ) ( 84,253 ) - Cancelled due to Plan expiration - - ( 193,705 ) Remaining available for grant 131,068 6,031 - Stock grants issued and outstanding: Total vested and unvested shares 18,932 95,888 - Fully vested shares - 48,675 - Option grants issued and outstanding: Total vested and unvested shares - 170,501 - Fully vested shares - 109,616 - Exercise price range $ - $ 23.75 to $ 42.62 $ -
Summary of Stock Option Activity	Changes in the stock options outstanding related to the Plans are summarized below (dollars in thousands except per share data): June 30, 2023 Number of Options Weighted Aggregate Outstanding at January 1, 2023 168,280 $ 33.95 $ 830 Issued 3,600 $ 35.13 Exercised ( 1,379 ) $ ( 13.69 ) Expired - $ - Outstanding at June 30, 2023 170,501 $ 34.14 $ 488 Options exercisable at June 30, 2023 109,616 $ 36.72 $ 222
Schedule of Options Outstanding and Exercisable, by Exercise Price Range	Summary information pertaining to options outstanding at June 30, 2023 is shown below. Share and per share data have been adjusted to reflect the prior stock dividends issued. Options Outstanding Options Exercisable Exercise Price Number of Weighted- Weighted- Number of Weighted- $ 23.75 to $ 30.00 65,000 7.0 Years $ 24.65 30,600 $ 24.90 $ 30.01 to $ 40.00 48,020 7.3 Years $ 36.83 21,536 $ 37.79 $ 40.01 to $ 42.62 57,481 4.9 Years $ 42.62 57,480 $ 42.62 Total 170,501 6.4 Years $ 34.14 109,616 $ 36.72
Summary of Changes in the Restricted Stock Grants Outstanding	Changes in the restricted stock grants outstanding during the six months ended June 30, 2023 are summarized below (dollars in thousands except per share data): June 30, 2023 Number of Weighted Aggregate Nonvested as of January 1, 2023 51,664 $ 32.05 $ 1,661 Issued 27,332 $ 32.73 $ 879 Vested ( 12,851 ) $ 30.40 $ ( 413 ) Forfeited - $ - $ - Nonvested at June 30, 2023 66,145 $ 32.65 $ 2,127

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Schedule of Available for Sale Securities Measured at Fair Value on a Recurring Basis	The following tables present the balances measured at fair value on a recurring basis as of June 30, 2023 and December 31, 2022 (dollars in thousands): Fair Value Measurements at June 30, 2023 Using: Quoted Prices Significant Significant Description Balance (Level 1) (Level 2) (Level 3) Assets: U.S. Government treasuries $ 175,551 $ - $ 175,551 $ - U.S. Government agencies 38,839 - 38,839 - Mortgage-backed securities/CMOs 157,788 - 157,788 - Corporate bonds 18,702 - 18,702 - Municipal bonds 82,988 - 82,988 - Total securities available for sale $ 473,868 $ - $ 473,868 $ - Fair Value Measurements at December 31, 2022 Using: Quoted Prices Significant Significant Description Balance (Level 1) (Level 2) (Level 3) Assets: U.S. Government treasuries $ 242,470 $ - $ 242,470 $ - U.S. Government agencies 28,755 - 28,755 - Mortgage-backed securities/CMOs 167,076 - 167,076 - Corporate bonds 18,729 - 18,729 Municipal bonds 81,156 - 81,156 - Total securities available for sale $ 538,186 $ - $ 538,186 $ - Liabilities: Interest rate swap liabilities $ 506 $ - $ 506 $ - Total liabilities at fair value $ 538,692 $ - $ 538,692 $ -
Summary of Assets Measured at Fair Value on a Nonrecurring Basis	The following table presents the Company's assets that were measured at fair value on a nonrecurring basis as of June 30, 2023 (dollars in thousands). There were no such assets to report as of December 31, 2022. Quoted Prices Significant Significant Description Balance (Level 1) (Level 2) (Level 3) Assets: Individually evaluated loans $ 461 $ - $ - $ 461 Description Fair Value Valuation Technique Unobservable Inputs Discount Rate Assets: Individually evaluated loans $ 461 Market comparables Discount applied to recent appraisal 20.0 %
Schedule of the Carrying Values and Estimated Fair Values of the Bank's Financial Instruments	The carrying values and estimated fair values of the Company's financial instruments as of June 30, 2023 and December 31, 2022 are as follows (dollars in thousands): Fair Value Measurements at June 30, 2023 Using: Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Carrying value Level 1 Level 2 Level 3 Fair Value Assets Cash and cash equivalent $ 29,939 $ 29,939 $ - $ - $ 29,939 Available for sale securities 473,868 - 473,868 - 473,868 Restricted securities 7,438 - 7,438 - 7,438 Loans, net 965,485 - - 902,429 902,429 Bank owned life insurance 39,065 - 39,065 - 39,065 Accrued interest receivable 5,092 - 2,137 2,955 5,092 Liabilities Demand deposits and interest-bearing transaction and money market accounts $ 1,123,120 $ - $ 1,123,120 $ - $ 1,123,120 Certificates of deposit 224,956 - 224,677 - 224,677 Federal funds purchased 20,503 $ - 20,503 $ - 20,503 FHLB Borrowings 59,666 - 59,717 - 59,717 Junior subordinated debt, net 3,436 - 3,436 - 3,436 Accrued interest payable 1,059 - 1,059 - 1,059 Fair Value Measurements at December 31, 2022 Using: Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Carrying value Level 1 Level 2 Level 3 Fair Value Assets Cash and cash equivalent $ 40,136 $ 40,136 $ - $ - $ 40,136 Available for sale securities 538,186 - 538,186 - 538,186 Restricted securities 5,137 - 5,137 - 5,137 Loans, net 930,863 - - 890,929 890,929 Assets held for sale 965 - 965 - 965 Bank owned life insurance 38,552 - 38,552 - 38,552 Accrued interest receivable 4,879 - 2,265 2,614 4,879 Interest rate swap asset 506 - 506 - 506 Liabilities Demand deposits and interest-bearing transaction and money market accounts $ 1,363,232 $ - $ 1,363,232 $ - $ 1,363,232 Certificates of deposit 115,106 - 109,260 - 109,260 Junior subordinated debt, net 3,413 - 3,413 - 3,413 Accrued interest payable 157 - 157 - 157

Other Comprehensive Income (L_2

Other Comprehensive Income (Loss) (Tables)	6 Months Ended
	Jun. 30, 2023
Other Comprehensive Income (Loss), Tax [Abstract]
Schedule of Components of Accumulated Other Comprehensive Income (Loss)	The following table presents the changes in each component of accumulated other comprehensive income (loss) as of June 30, 2023 and June 30, 2022 (dollars in thousands). AFS Securities Interest Rate Swap Total Accumulated other comprehensive income (loss) at December 31, 2022 $ ( 49,024 ) $ 400 $ ( 48,624 ) Other comprehensive income (loss) arising during the period 3,647 ( 46 ) 3,601 Related income tax effects ( 766 ) 9 ( 757 ) 2,881 ( 37 ) 2,844 Reclassification into net income 206 ( 460 ) ( 254 ) Related income tax effects ( 43 ) 97 54 163 ( 363 ) ( 200 ) Accumulated other comprehensive loss at June 30, 2023 $ ( 45,980 ) $ — $ ( 45,980 ) AFS Securities Interest Rate Swap Total Accumulated other comprehensive loss at December 31, 2021 $ ( 2,164 ) $ ( 47 ) $ ( 2,211 ) Other comprehensive income (loss) arising during the period ( 45,415 ) 499 ( 44,916 ) Related income tax effects 9,536 ( 104 ) 9,432 ( 35,879 ) 395 ( 35,484 ) Accumulated other comprehensive income (loss) at June 30, 2022 $ ( 38,043 ) $ 348 $ ( 37,695 )

Derivatives Instruments and H_2

Derivatives Instruments and Hedging Activities (Tables)	6 Months Ended
	Jun. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Summary of Derivative Instruments	The follow table summarizes the Company’s deriva tive instruments as of December 31, 2022 (dollars in thousands): December 31, 2022 Derivatives designated as hedging instruments Notional/ Contract Amount Fair Value Fair Value Balance Sheet Location Expiration Date Interest rate forward swap - cash flow $ 4,000 $ 506 Junior subordinated debt 6/15/2031

Segment Reporting (Tables)

Segment Reporting (Tables)	6 Months Ended
	Jun. 30, 2023
Segment Reporting [Abstract]
Schedule of segment reporting information	Segment information for the three and six months ended June 30, 2023 and 2022 is shown in the following tables (dollars in thousands). Note that asset information is not reported below, as the assets of VNB Trust & Estate Services are reported at the Bank level and the assets of Sturman Wealth Advisors were reported at the Bank level prior to the sale of the business line on December 19, 2022; also, assets specifically allocated to the lines of business other than the Bank are insignificant and are no longer provided to the chief operating decision maker. Three months ended June 30, 2023 Bank VNB Trust & Masonry Consolidated Net interest income $ 13,703 $ - $ - $ 13,703 Provision for credit losses 261 - - 261 Noninterest income 1,637 250 158 2,045 Noninterest expense 7,987 361 216 8,564 Income (loss) before income taxes 7,092 ( 111 ) ( 58 ) 6,923 Provision for (benefit from) income 1,308 ( 24 ) ( 12 ) 1,272 Net income (loss) $ 5,784 $ ( 87 ) $ ( 46 ) $ 5,651 Six months ended June 30, 2023 Bank VNB Trust & Masonry Consolidated Net interest income $ 27,116 $ - $ - $ 27,116 Provision for credit losses 13 - - 13 Noninterest income 3,492 510 319 4,321 Noninterest expense 16,355 672 398 17,425 Income (loss) before income taxes 14,240 ( 162 ) ( 79 ) 13,999 Provision for (benefit from) income taxes 2,607 ( 34 ) ( 16 ) 2,557 Net income (loss) $ 11,633 $ ( 128 ) $ ( 63 ) $ 11,442 Three months ended June 30, 2022 Bank Sturman Wealth Advisors VNB Trust & Masonry Consolidated Net interest income $ 12,461 $ - $ - $ - $ 12,461 Provision for (recovery of) credit losses ( 217 ) - - - ( 217 ) Noninterest income 2,851 210 365 220 3,646 Noninterest expense 8,717 161 376 188 9,442 Income (loss) before income taxes 6,812 49 ( 11 ) 32 6,882 Provision for (benefit from) income 1,181 11 ( 2 ) 7 1,197 Net income (loss) $ 5,631 $ 38 $ ( 9 ) $ 25 $ 5,685 Six months ended June 30, 2022 Bank Sturman Wealth Advisors VNB Trust & Masonry Consolidated Net interest income $ 23,886 $ - $ - $ - $ 23,886 Provision for (recovery of) credit losses ( 69 ) - - - ( 69 ) Noninterest income 4,385 426 3,196 426 8,433 Noninterest expense 17,538 327 1,298 374 19,537 Income before income taxes 10,802 99 1,898 52 12,851 Provision for income taxes 1,811 21 399 11 2,242 Net income $ 8,991 $ 78 $ 1,499 $ 41 $ 10,609

Adoption of New Accounting St_3

Adoption of New Accounting Standards - Additional Information (Details) - USD ($) $ in Thousands		3 Months Ended
	Jan. 01, 2023	Mar. 31, 2023	Jun. 30, 2023	Dec. 31, 2022	[1]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Increase in ACL		$ 2,491
Adjustment to retained earnings			$ 69,502	$ 63,482
Accrued interest receivable			$ 2,900
ASU 2016-13 [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Adjustment to retained earnings	$ 1,900
ASU 2016-13 [Member] | Loans [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Increase in ACL	2,500
ASU 2016-13 [Member] | Unfunded Loan Commitment [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Increase in ACL	252,000
PCD Loans [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Expected credit losses to amortized cost basis of loans	$ 355
[1] Derived from audited Consolidated Financial Statements

Adoption of New Accounting St_4

Adoption of New Accounting Standards - Schedule of Impact of Adopting ASC 326 (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Jan. 01, 2023	Dec. 31, 2022
Assets [Abstract]
Loans, gross	$ 973,348		$ 936,415	[1]
Allowance for credit losses	7,863		5,552	[1]
Loans, net	965,485		930,863	[1]
Net deferred tax asset	16,961		17,315	[1]
Liabilities [Abstract]
Total equity	$ 1,584,088		1,623,359	[1]
As Previously Reported (Incurred Loss) [Member]
Assets [Abstract]
Loans, gross			936,415
Allowance for credit losses			5,552
Loans, net			930,863
Net deferred tax asset			17,315
Liabilities [Abstract]
Reserve for credit losses on unfunded commitments			60
Total equity			133,416
Commercial [Member] | As Previously Reported (Incurred Loss) [Member]
Assets [Abstract]
Allowance for credit losses			194
Real Estate Construction and Land [Member] | As Previously Reported (Incurred Loss) [Member]
Assets [Abstract]
Allowance for credit losses			221
1-4 family residential mortgages [Member] | As Previously Reported (Incurred Loss) [Member]
Assets [Abstract]
Allowance for credit losses			1,618
Commercial mortgages [Member] | As Previously Reported (Incurred Loss) [Member]
Assets [Abstract]
Allowance for credit losses			2,820
Consumer [Member] | As Previously Reported (Incurred Loss) [Member]
Assets [Abstract]
Allowance for credit losses			$ 699
ASU 2016-13 [Member]
Assets [Abstract]
Loans, gross		$ 936,770
Allowance for credit losses		8,044
Loans, net		928,726
Net deferred tax asset		17,814
Liabilities [Abstract]
Reserve for credit losses on unfunded commitments		313
Total equity		131,526
ASU 2016-13 [Member] | Impact of ASC 326 [Member]
Assets [Abstract]
Loans, gross		355
Allowance for credit losses		2,491
Loans, net		(2,136)
Net deferred tax asset		499
Liabilities [Abstract]
Reserve for credit losses on unfunded commitments		253
Total equity		(1,890)
ASU 2016-13 [Member] | Commercial [Member]
Assets [Abstract]
Allowance for credit losses		183
ASU 2016-13 [Member] | Commercial [Member] | Impact of ASC 326 [Member]
Assets [Abstract]
Allowance for credit losses		(11)
ASU 2016-13 [Member] | Real Estate Construction and Land [Member]
Assets [Abstract]
Allowance for credit losses		661
ASU 2016-13 [Member] | Real Estate Construction and Land [Member] | Impact of ASC 326 [Member]
Assets [Abstract]
Allowance for credit losses		440
ASU 2016-13 [Member] | 1-4 family residential mortgages [Member]
Assets [Abstract]
Allowance for credit losses		1,632
ASU 2016-13 [Member] | 1-4 family residential mortgages [Member] | Impact of ASC 326 [Member]
Assets [Abstract]
Allowance for credit losses		14
ASU 2016-13 [Member] | Commercial mortgages [Member]
Assets [Abstract]
Allowance for credit losses		4,397
ASU 2016-13 [Member] | Commercial mortgages [Member] | Impact of ASC 326 [Member]
Assets [Abstract]
Allowance for credit losses		1,577
ASU 2016-13 [Member] | Consumer [Member]
Assets [Abstract]
Allowance for credit losses		1,171
ASU 2016-13 [Member] | Consumer [Member] | Impact of ASC 326 [Member]
Assets [Abstract]
Allowance for credit losses		$ 471
[1] Derived from audited Consolidated Financial Statements

Securities (Amortized Cost and

Securities (Amortized Cost and Fair Values of Securities Available for Sale) (Details)) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 532,072	$ 600,242
Gross Unrealized (Losses)	(58,204)	(62,056)
Available for Sale, Fair Value	473,868	538,186	[1]
U.S. Government treasuries [Member]
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	177,277	245,583
Gross Unrealized (Losses)	(1,726)	(3,113)
Available for Sale, Fair Value	175,551	242,470
U.S. Government Agencies [Member]
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	45,179	35,283
Gross Unrealized (Losses)	(6,340)	(6,528)
Available for Sale, Fair Value	38,839	28,755
Mortgage-backed Securities/CMOs [Member]
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	185,436	194,964
Gross Unrealized (Losses)	(27,648)	(27,888)
Available for Sale, Fair Value	157,788	167,076
Municipal Bonds [Member]
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	104,550	104,831
Gross Unrealized (Losses)	(21,562)	(23,675)
Available for Sale, Fair Value	82,988	81,156
Corporate Bonds [Member]
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	19,630	19,581
Gross Unrealized (Losses)	(928)	(852)
Available for Sale, Fair Value	$ 18,702	$ 18,729
[1] Derived from audited Consolidated Financial Statements

Securities (Narrative) (Details

Securities (Narrative) (Details)	3 Months Ended		6 Months Ended
	Jun. 30, 2023 USD ($) Item	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) Item	Jun. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)
Schedule of Investments [Line Items]
Available-for-sale securities, continuous unrealized loss position, fair value	$ 471,846,000		$ 471,846,000		$ 536,868,000
Number of securities designated as available for sale securities having unrealized loss | Item	288		288
Accrued interest receivable	$ 2,900,000		$ 2,900,000
Unrealized loss of available for sale securities	58,204,000		58,204,000		62,056,000
Securities, allowance for credit losses	0		0		0
Proceeds from the sales of securities	0	$ 0	49,900,000	$ 0
Available for sale securities pre-tax loss			206,000
Restricted securities, at cost	7,438,000		7,438,000		5,137,000	[1]
Mortgage-backed Securities/CMOs [Member]
Schedule of Investments [Line Items]
Available-for-sale securities, continuous unrealized loss position, fair value	$ 157,788,000		$ 157,788,000		167,085,000
Number of securities designated as available for sale securities having unrealized loss | Item	120		120
Unrealized loss of available for sale securities	$ 27,648,000		$ 27,648,000		27,888,000
U.S. Government Agencies [Member]
Schedule of Investments [Line Items]
Available-for-sale securities, continuous unrealized loss position, fair value	$ 38,838,000		$ 38,838,000		28,503,000
Number of securities designated as available for sale securities having unrealized loss | Item	21		21
Unrealized loss of available for sale securities	$ 6,340,000		$ 6,340,000		6,528,000
Corporate Bonds [Member]
Schedule of Investments [Line Items]
Available-for-sale securities, continuous unrealized loss position, fair value	$ 18,703,000		$ 18,703,000		18,729,000
Number of securities designated as available for sale securities having unrealized loss | Item	11		11
Unrealized loss of available for sale securities	$ 928,000		$ 928,000		852,000
Treasury bond [Member]
Schedule of Investments [Line Items]
Number of securities designated as available for sale securities having unrealized loss | Item	11		11
Asset Pledged as Collateral without Right [Member]
Schedule of Investments [Line Items]
Securities pledged to secure deposits and facilitate borrowing	$ 3,100,000		$ 3,100,000		3,000,000
Asset Pledged as Collateral without Right [Member] | Public Funds Depository Accounts [Member]
Schedule of Investments [Line Items]
Securities pledged to secure deposits and facilitate borrowing	18,200,000		18,200,000		2,100,000
Municipal Bonds [Member]
Schedule of Investments [Line Items]
Available-for-sale securities, continuous unrealized loss position, fair value	$ 80,966,000		$ 80,966,000		80,081,000
Number of securities designated as available for sale securities having unrealized loss | Item	125		125
Unrealized loss of available for sale securities	$ 21,562,000		$ 21,562,000		$ 23,675,000
AFS Securities [Member]
Schedule of Investments [Line Items]
Accrued interest receivable	$ 2,100,000		$ 2,100,000
[1] Derived from audited Consolidated Financial Statements

Securities (Schedule of Unreali

Securities (Schedule of Unrealized Losses) (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Continuous Unrealized Loss Position of Less Than 12 Months, Estimated Fair value	$ 120,136	$ 364,997
Continuous Unrealized Loss Position of Less Than 12 Months, Unrealized losses	(1,526)	(18,596)
Continuous Unrealized Loss Position of 12 Months or More, Estimated Fair value	351,710	171,871
Continuous Unrealized Loss Position of 12 Months or More, Unrealized losses	(56,678)	(43,460)
Total, Estimated Fair value	471,846	536,868
Total, Unrealized losses	(58,204)	(62,056)
U.S. Government treasuries [Member]
Debt Securities, Available-for-sale [Line Items]
Continuous Unrealized Loss Position of Less Than 12 Months, Estimated Fair value	84,250	242,470
Continuous Unrealized Loss Position of Less Than 12 Months, Unrealized losses	(238)	(3,113)
Continuous Unrealized Loss Position of 12 Months or More, Estimated Fair value	91,301
Continuous Unrealized Loss Position of 12 Months or More, Unrealized losses	(1,488)
Total, Estimated Fair value	175,551	242,470
Total, Unrealized losses	(1,726)	(3,113)
U.S. Government Agencies [Member]
Debt Securities, Available-for-sale [Line Items]
Continuous Unrealized Loss Position of Less Than 12 Months, Estimated Fair value	10,107	4,285
Continuous Unrealized Loss Position of Less Than 12 Months, Unrealized losses	(53)	(620)
Continuous Unrealized Loss Position of 12 Months or More, Estimated Fair value	28,731	24,218
Continuous Unrealized Loss Position of 12 Months or More, Unrealized losses	(6,287)	(5,908)
Total, Estimated Fair value	38,838	28,503
Total, Unrealized losses	(6,340)	(6,528)
Mortgage-backed Securities/CMOs [Member]
Debt Securities, Available-for-sale [Line Items]
Continuous Unrealized Loss Position of Less Than 12 Months, Estimated Fair value	13,028	55,396
Continuous Unrealized Loss Position of Less Than 12 Months, Unrealized losses	(730)	(6,010)
Continuous Unrealized Loss Position of 12 Months or More, Estimated Fair value	144,760	111,689
Continuous Unrealized Loss Position of 12 Months or More, Unrealized losses	(26,918)	(21,878)
Total, Estimated Fair value	157,788	167,085
Total, Unrealized losses	(27,648)	(27,888)
Corporate Bonds [Member]
Debt Securities, Available-for-sale [Line Items]
Continuous Unrealized Loss Position of Less Than 12 Months, Estimated Fair value	9,628	18,729
Continuous Unrealized Loss Position of Less Than 12 Months, Unrealized losses	(403)	(852)
Continuous Unrealized Loss Position of 12 Months or More, Estimated Fair value	9,075
Continuous Unrealized Loss Position of 12 Months or More, Unrealized losses	(525)
Total, Estimated Fair value	18,703	18,729
Total, Unrealized losses	(928)	(852)
Municipal Bonds [Member]
Debt Securities, Available-for-sale [Line Items]
Continuous Unrealized Loss Position of Less Than 12 Months, Estimated Fair value	3,123	44,117
Continuous Unrealized Loss Position of Less Than 12 Months, Unrealized losses	(102)	(8,001)
Continuous Unrealized Loss Position of 12 Months or More, Estimated Fair value	77,843	35,964
Continuous Unrealized Loss Position of 12 Months or More, Unrealized losses	(21,460)	(15,674)
Total, Estimated Fair value	80,966	80,081
Total, Unrealized losses	$ (21,562)	$ (23,675)

Securities (Schedule of Amortiz

Securities (Schedule of Amortized Cost and Fair Values of Securities Available For Sale Based upon Contractual Maturities and by Major Investment Categories) (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Amortized Cost
Amortized Cost	$ 532,072	$ 600,242
Fair Value
Total Securities Available for Sale	473,868
U.S. Government treasuries [Member]
Amortized Cost
One year or less	165,818
After one year to five years	11,459
Amortized Cost	177,277	245,583
Fair Value
One year or less	164,439
After one year to five years	11,112
Total Securities Available for Sale	157,788
U.S. Government Agencies [Member]
Amortized Cost
One year or less	10,000
After one year to five years	5,802
After five years to ten years	25,377
Ten years or more	4,000
Amortized Cost	45,179	35,283
Fair Value
One year or less	9,948
After one year to five years	5,049
After five years to ten years	20,918
Ten years or more	2,924
Total Securities Available for Sale	38,839
Mortgage-backed Securities/CMOs [Member]
Amortized Cost
One year or less	2,954
After one year to five years	6,452
After five years to ten years	3,185
Ten years or more	172,845
Amortized Cost	185,436	194,964
Fair Value
One year or less	2,890
After one year to five years	6,051
After five years to ten years	2,878
Ten years or more	145,969
Total Securities Available for Sale	175,551
Corporate Bonds [Member]
Amortized Cost
One year or less	1,002
After one year to five years	18,628
Amortized Cost	19,630	19,581
Fair Value
One year or less	977
After one year to five years	17,725
Total Securities Available for Sale	18,702
Municipal Bonds [Member]
Amortized Cost
After one year to five years	3,060
After five years to ten years	19,892
Ten years or more	81,598
Amortized Cost	104,550	$ 104,831
Fair Value
After one year to five years	2,922
After five years to ten years	18,089
Ten years or more	61,977
Total Securities Available for Sale	$ 82,988

Loans (Narrative) (Details)

Loans (Narrative) (Details) $ in Thousands	3 Months Ended		6 Months Ended	12 Months Ended
	Jun. 30, 2023 USD ($)	Mar. 31, 2023 USD ($)	Jun. 30, 2023 USD ($) Loan	Dec. 31, 2022 USD ($)	Jun. 30, 2022 USD ($)	Apr. 01, 2021 USD ($)
Loans And Leases Receivable Disclosure [Line Items]
Accrued interest receivable	$ 2,900		$ 2,900
Deposit account overdrafts	58		58	$ 180
Unamortized premium	1,800		1,800	1,800
Net deferred loan costs (fees)	(1,700)		(1,700)	(755)
Due to collateral value shortfall	19		$ 19
Number of non accrual loans required allowance of credit loss | Loan			1
Nonaccrual Loans	1,185		$ 1,185	673
Loans modified				1,283	$ 0
Charged off	180	$ 142		1,255
ASU 2022-02 [Member]
Loans And Leases Receivable Disclosure [Line Items]
Number of non accrual loans required allowance of credit loss | Loan			2
Nonaccrual Loans	534		$ 534
Performing Loans [Member]
Loans And Leases Receivable Disclosure [Line Items]
Loans modified				788
Purchased Impaired Loan [Member] | Fauquier Bankshares, Inc [Member]
Loans And Leases Receivable Disclosure [Line Items]
Loan receivable at fair value net	11,000		11,000			$ 23,100
1-4 family residential-purchased [Member]
Loans And Leases Receivable Disclosure [Line Items]
Nonaccrual Loans	$ 713		$ 713	673
1-4 family residential-purchased [Member] | Performing Loans [Member]
Loans And Leases Receivable Disclosure [Line Items]
Loans modified				$ 88

Loans (Schedule of Composition

Loans (Schedule of Composition of Loan Portfolio by Major Loan Classifications) (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	$ 973,348	$ 936,415
Less: Allowance for credit losses	(7,863)	(5,552)	[1]
Loans, net	965,485	930,863	[1]
Commercial [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	98,312	71,139
Real Estate Construction and Land [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	29,825	37,541
1-4 family residential mortgages [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	317,330	323,185
Commercial mortgages [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	486,643	459,125
Consumer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	$ 41,238	$ 45,425
[1] Derived from audited Consolidated Financial Statements

Loans (Summary of Outstanding P

Loans (Summary of Outstanding Principal Balance and Carrying Amount of Loans Acquired in Business Combination) (Details) - Fauquier Bankshares, Inc [Member] $ in Thousands	Dec. 31, 2022 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Contractual principal and interest at acquisition	$ 333,854
Total acquired loans	317,966
Acquired Loans - Purchased Credit Impaired [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Contractual principal and interest at acquisition	43,250
Total acquired loans	32,067
Acquired Loans - Purchased Performing [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Contractual principal and interest at acquisition	290,604
Total acquired loans	285,899
Commercial [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total acquired loans	13,236
Commercial [Member] | Acquired Loans - Purchased Credit Impaired [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total acquired loans	630
Commercial [Member] | Acquired Loans - Purchased Performing [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total acquired loans	12,606
Real Estate Construction and Land [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total acquired loans	9,991
Real Estate Construction and Land [Member] | Acquired Loans - Purchased Credit Impaired [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total acquired loans	1,461
Real Estate Construction and Land [Member] | Acquired Loans - Purchased Performing [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total acquired loans	8,530
1-4 Family Residential Mortgages [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total acquired loans	173,356
1-4 Family Residential Mortgages [Member] | Acquired Loans - Purchased Credit Impaired [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total acquired loans	9,076
1-4 Family Residential Mortgages [Member] | Acquired Loans - Purchased Performing [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total acquired loans	164,280
Commercial Mortgages [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total acquired loans	120,034
Commercial Mortgages [Member] | Acquired Loans - Purchased Credit Impaired [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total acquired loans	20,828
Commercial Mortgages [Member] | Acquired Loans - Purchased Performing [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total acquired loans	99,206
Consumer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total acquired loans	1,349
Consumer [Member] | Acquired Loans - Purchased Credit Impaired [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total acquired loans	72
Consumer [Member] | Acquired Loans - Purchased Performing [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total acquired loans	$ 1,277

Loans (Summary of Changes in Ac

Loans (Summary of Changes in Accretable Yield of Loans Classified as Purchased Credit Impaired) (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Reclassification from nonaccretable difference		$ 2,193
Other changes, net		(2,768)
Fauquier Bankshares, Inc [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accretable yield, beginning of period	$ 12,428	13,742
Accretion	(761)	(1,500)
Accretable yield, end of period	$ 11,667	$ 11,667

Loans - (Schedule of Aging of P

Loans - (Schedule of Aging of Past Due Loans) (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Financing Receivable Recorded Investment Past Due [Line Items]
90 Days Past Due and Still Accruing	$ 107	$ 705
Nonaccrual Loans	1,185	673
PCI		32,067
Total Loans	973,348	936,415
30-59 Days [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due	1,788	2,108
60-89 Days [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due	60	256
90 Days or More [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due		1,378
Past Due [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due		3,742
Current [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due	970,208	900,606
Commercial [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due	98,312
PCI		630
Total Loans	98,312	71,139
Commercial [Member] | 30-59 Days [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due	793
Commercial [Member] | 60-89 Days [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due		24
Commercial [Member] | 90 Days or More [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due
Commercial [Member] | Past Due [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due		24
Commercial [Member] | Current [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due	97,519	70,485
Real Estate Construction and Land [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due	29,825
PCI		1,461
Total Loans	29,825	37,541
Real Estate Construction and Land [Member] | 30-59 Days [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due		287
Real Estate Construction and Land [Member] | 90 Days or More [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due		75
Real Estate Construction and Land [Member] | Past Due [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due		362
Real Estate Construction and Land [Member] | Current [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due	29,825	35,718
1-4 family residential mortgages [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due	317,330
Nonaccrual Loans	713
PCI		9,076
Total Loans	317,330	323,185
1-4 family residential mortgages [Member] | 30-59 Days [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due	292	1,176
1-4 family residential mortgages [Member] | 60-89 Days [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due	59	191
1-4 family residential mortgages [Member] | 90 Days or More [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due		598
1-4 family residential mortgages [Member] | Past Due [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due		1,965
1-4 family residential mortgages [Member] | Current [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due	316,266	312,144
Commercial Mortgages [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due	486,643
90 Days Past Due and Still Accruing		646
Nonaccrual Loans	472
PCI		20,828
Total Loans	486,643	459,125
Commercial Mortgages [Member] | 30-59 Days [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due	439	330
Commercial Mortgages [Member] | 60-89 Days [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due
Commercial Mortgages [Member] | 90 Days or More [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due		646
Commercial Mortgages [Member] | Past Due [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due		976
Commercial Mortgages [Member] | Current [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due	485,732	437,321
Consumer Loans [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due	41,238
90 Days Past Due and Still Accruing	107	59
PCI		72
Total Loans	41,238	45,425
Consumer Loans [Member] | 30-59 Days [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due	264	315
Consumer Loans [Member] | 60-89 Days [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due	1	41
Consumer Loans [Member] | 90 Days or More [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due		59
Consumer Loans [Member] | Past Due [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due		415
Consumer Loans [Member] | Current [Member]
Financing Receivable Recorded Investment Past Due [Line Items]
Total Past Due	$ 40,866	$ 44,938

Loans (Non-Accrual Loans by Loa

Loans (Non-Accrual Loans by Loan Classification) (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Financing Receivable, Credit Quality Indicator [Line Items]
Nonaccrual Loans with No Allowance	$ 705
Nonaccrual Loans with an Allowance	480
Total non-accrual loans	1,185	$ 673
Commercial Mortgages [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Nonaccrual Loans with No Allowance	472
Total non-accrual loans	472
1-4 Family Residential Mortgages [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Nonaccrual Loans with No Allowance	233
Nonaccrual Loans with an Allowance	480
Total non-accrual loans	$ 713	$ 673

Loans (Schedule of Troubled Deb

Loans (Schedule of Troubled Debt Restructurings) (Details) $ in Thousands	Dec. 31, 2022 USD ($) Loan	Jun. 30, 2022 USD ($)
Financing Receivable, Credit Quality Indicator [Line Items]
Number of loans | Loan	49
Total Troubled Debt Restructurings | $	$ 1,283	$ 0
Performing [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Number of loans | Loan	47
Total Troubled Debt Restructurings | $	$ 788
Performing [Member] | 1-4 Family Residential Mortgages [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Number of loans | Loan	1
Total Troubled Debt Restructurings | $	$ 88
Performing [Member] | Consumer [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Number of loans | Loan	46
Total Troubled Debt Restructurings | $	$ 700
Nonperforming [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Number of loans | Loan	2
Total Troubled Debt Restructurings | $	$ 495
Nonperforming [Member] | 1-4 Family Residential Mortgages [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Number of loans | Loan	2
Total Troubled Debt Restructurings | $	$ 495

Allowance for Credit Losses (Na

Allowance for Credit Losses (Narrative) (Details) $ in Thousands	Jun. 30, 2023 USD ($)
Financing Receivable, Credit Quality Indicator [Line Items]
Specific reserve for nonaccrual status	$ 19

Allowance for Credit Losses (Su

Allowance for Credit Losses (Summary of Transactions in Allowance for Credit Losses by Major Loan Portfolio Segment) (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended		12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Allowance for Loan Losses:
Beginning Balance	$ 7,772	$ 5,552		$ 5,552	$ 5,984	$ 5,984
Impact of ASC 326 adoption		2,491
Charge-offs	(180)	(142)				(1,255)
Recoveries	55	106				717
Provision for (recovery of) credit losses	216	(235)	$ (217)	(19)	(69)	106
Ending Balance	7,863	7,772		7,863		5,552
Ending balance: Individually evaluated for impairment						23
Ending balance: Collectively evaluated for impairment						5,529
Loans:
Individually evaluated for impairment						1,283
Collectively evaluated for impairment						903,065
Acquired loans - purchased credit impaired						32,067
Ending Balance	973,348			973,348		936,415
Commercial Loans [Member]
Allowance for Loan Losses:
Beginning Balance	176	194		194	252	252
Impact of ASC 326 adoption		(11)
Charge-offs						(600)
Recoveries	20					519
Provision for (recovery of) credit losses	19	(7)				23
Ending Balance	215	176		215		194
Ending balance: Collectively evaluated for impairment						194
Loans:
Collectively evaluated for impairment						70,509
Acquired loans - purchased credit impaired						630
Ending Balance	98,312			98,312		71,139
Real Estate Construction and Land [Member]
Allowance for Loan Losses:
Beginning Balance	571	221		221	399	399
Impact of ASC 326 adoption		440
Recoveries						9
Provision for (recovery of) credit losses	(107)	(90)				(187)
Ending Balance	464	571		464		221
Ending balance: Collectively evaluated for impairment						221
Loans:
Collectively evaluated for impairment						36,080
Acquired loans - purchased credit impaired						1,461
Ending Balance	29,825			29,825		37,541
1-4 family residential mortgages [Member]
Allowance for Loan Losses:
Beginning Balance	1,560	1,618		1,618
Impact of ASC 326 adoption		14
Recoveries	2	3
Provision for (recovery of) credit losses	715	(75)
Ending Balance	2,277	1,560		2,277		1,618
Loans:
Acquired loans - purchased credit impaired						9,076
Ending Balance	317,330			317,330		323,185
Commercial Mortgages [Member]
Allowance for Loan Losses:
Beginning Balance	4,471	2,820		2,820
Impact of ASC 326 adoption		1,577
Recoveries		41
Provision for (recovery of) credit losses	(516)	33
Ending Balance	3,955	4,471		3,955		2,820
Loans:
Acquired loans - purchased credit impaired						20,828
Ending Balance	486,643			486,643		459,125
Real Estate Mortgages [Member]
Allowance for Loan Losses:
Beginning Balance		4,438		4,438	4,478	4,478
Recoveries						11
Provision for (recovery of) credit losses						(51)
Ending Balance						4,438
Ending balance: Collectively evaluated for impairment						4,438
Loans:
Individually evaluated for impairment						583
Collectively evaluated for impairment						751,823
Acquired loans - purchased credit impaired						29,904
Ending Balance						782,310
Consumer Loans [Member]
Allowance for Loan Losses:
Beginning Balance	994	699		699	$ 855	855
Impact of ASC 326 adoption		471
Charge-offs	(180)	(142)				(655)
Recoveries	33	62				178
Provision for (recovery of) credit losses	105	(96)				321
Ending Balance	952	$ 994		952		699
Ending balance: Individually evaluated for impairment						23
Ending balance: Collectively evaluated for impairment						676
Loans:
Individually evaluated for impairment						700
Collectively evaluated for impairment						44,653
Acquired loans - purchased credit impaired						72
Ending Balance	$ 41,238			$ 41,238		$ 45,425

Allowance for Credit Losses (_2

Allowance for Credit Losses (Summary of Provision for Credit Losses) (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended		12 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Financing Receivable, Credit Quality Indicator [Line Items]
Provision (recovery) for loans	$ 216	$ (235)	$ (217)	$ (19)	$ (69)	$ 106
Provision for unfunded commitments	45			32
Total	$ 261		$ (217)	$ 13	$ (69)

Allowance for Credit Losses - S

Allowance for Credit Losses - Summary of Amortized Cost Basis of Collateral Dependent Loans Individually Evaluated to Determine Expected Credit Losses, and Related ACL Allocated to Loans (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for Credit Losses - Loans	$ 7,863	$ 7,772	$ 5,552	$ 5,984
Collateral Dependent Loans [Member]
Financing Receivable, Allowance for Credit Loss [Line Items]
Real Estate Secured Loans	1,439
Allowance for Credit Losses - Loans	19
Commercial real estate - non owner occupied [Member] | Collateral Dependent Loans [Member]
Financing Receivable, Allowance for Credit Loss [Line Items]
Real Estate Secured Loans	698
Residential 1-4 family real estate [Member] | Collateral Dependent Loans [Member]
Financing Receivable, Allowance for Credit Loss [Line Items]
Real Estate Secured Loans	741
Allowance for Credit Losses - Loans	$ 19

Allowance for Credit Losses (_3

Allowance for Credit Losses (Summary of Investment in Loans by Credit Quality Indicators by Year of Origination) (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2023 USD ($)
Financing Receivable, Credit Quality Indicator [Line Items]
Current period gross write-off, 2021	$ 17
Current period gross write-off, 2020	1
Current period gross write-off, 2019	27
Current period gross write-off, Prior	273
Current period gross write-off, Revolving Loans	4
Current period gross write-off	322
Commercial [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, 2023	28,457
Term Loans Amortized Cost Basis by Origination Year, 2022	12,935
Term Loans Amortized Cost Basis by Origination Year, 2021	3,112
Term Loans Amortized Cost Basis by Origination Year, 2020	5,999
Term Loans Amortized Cost Basis by Origination Year, 2019	9,026
Term Loans Amortized Cost Basis by Origination Year, Prior	15,366
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	22,916
Term Loans Amortized Cost Basis by Origination Year, Loans Converted to Term	501
Term Loans Amortized Cost Basis by Origination Year, Total	98,312
Commercial [Member] | Pass [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, 2023	28,457
Term Loans Amortized Cost Basis by Origination Year, 2022	12,818
Term Loans Amortized Cost Basis by Origination Year, 2021	3,101
Term Loans Amortized Cost Basis by Origination Year, 2020	5,959
Term Loans Amortized Cost Basis by Origination Year, 2019	8,560
Term Loans Amortized Cost Basis by Origination Year, Prior	15,005
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	22,694
Term Loans Amortized Cost Basis by Origination Year, Loans Converted to Term	14
Term Loans Amortized Cost Basis by Origination Year, Total	96,608
Commercial [Member] | Watch [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, 2022	44
Term Loans Amortized Cost Basis by Origination Year, 2019	122
Term Loans Amortized Cost Basis by Origination Year, Prior	7
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	7
Term Loans Amortized Cost Basis by Origination Year, Total	180
Commercial [Member] | Special Mention [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, 2021	1
Term Loans Amortized Cost Basis by Origination Year, Prior	93
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	215
Term Loans Amortized Cost Basis by Origination Year, Total	309
Commercial [Member] | Substandard [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, 2022	73
Term Loans Amortized Cost Basis by Origination Year, 2021	10
Term Loans Amortized Cost Basis by Origination Year, 2020	40
Term Loans Amortized Cost Basis by Origination Year, 2019	344
Term Loans Amortized Cost Basis by Origination Year, Prior	261
Term Loans Amortized Cost Basis by Origination Year, Loans Converted to Term	487
Term Loans Amortized Cost Basis by Origination Year, Total	1,215
Real Estate Construction and Land [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, 2023	3,665
Term Loans Amortized Cost Basis by Origination Year, 2022	13,539
Term Loans Amortized Cost Basis by Origination Year, 2021	4,512
Term Loans Amortized Cost Basis by Origination Year, 2020	1,754
Term Loans Amortized Cost Basis by Origination Year, 2019	1,304
Term Loans Amortized Cost Basis by Origination Year, Prior	5,051
Term Loans Amortized Cost Basis by Origination Year, Total	29,825
Real Estate Construction and Land [Member] | Pass [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, 2023	3,665
Term Loans Amortized Cost Basis by Origination Year, 2022	13,539
Term Loans Amortized Cost Basis by Origination Year, 2021	4,512
Term Loans Amortized Cost Basis by Origination Year, 2020	1,754
Term Loans Amortized Cost Basis by Origination Year, 2019	940
Term Loans Amortized Cost Basis by Origination Year, Prior	2,932
Term Loans Amortized Cost Basis by Origination Year, Total	27,342
Real Estate Construction and Land [Member] | Watch [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, Prior	329
Term Loans Amortized Cost Basis by Origination Year, Total	329
Real Estate Construction and Land [Member] | Special Mention [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, Prior	750
Term Loans Amortized Cost Basis by Origination Year, Total	750
Real Estate Construction and Land [Member] | Substandard [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, 2019	364
Term Loans Amortized Cost Basis by Origination Year, Prior	1,040
Term Loans Amortized Cost Basis by Origination Year, Total	1,404
1-4 family residential mortgages [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, 2023	9,025
Term Loans Amortized Cost Basis by Origination Year, 2022	17,243
Term Loans Amortized Cost Basis by Origination Year, 2021	58,232
Term Loans Amortized Cost Basis by Origination Year, 2020	79,793
Term Loans Amortized Cost Basis by Origination Year, 2019	25,909
Term Loans Amortized Cost Basis by Origination Year, Prior	102,768
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	23,973
Term Loans Amortized Cost Basis by Origination Year, Loans Converted to Term	387
Term Loans Amortized Cost Basis by Origination Year, Total	317,330
1-4 family residential mortgages [Member] | Pass [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, 2023	9,025
Term Loans Amortized Cost Basis by Origination Year, 2022	14,994
Term Loans Amortized Cost Basis by Origination Year, 2021	57,925
Term Loans Amortized Cost Basis by Origination Year, 2020	77,837
Term Loans Amortized Cost Basis by Origination Year, 2019	25,810
Term Loans Amortized Cost Basis by Origination Year, Prior	93,193
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	23,425
Term Loans Amortized Cost Basis by Origination Year, Loans Converted to Term	387
Term Loans Amortized Cost Basis by Origination Year, Total	302,596
1-4 family residential mortgages [Member] | Watch [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, 2022	1,396
Term Loans Amortized Cost Basis by Origination Year, 2021	125
Term Loans Amortized Cost Basis by Origination Year, 2020	1,449
Term Loans Amortized Cost Basis by Origination Year, Prior	6,025
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	470
Term Loans Amortized Cost Basis by Origination Year, Total	9,465
1-4 family residential mortgages [Member] | Special Mention [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, 2022	853
Term Loans Amortized Cost Basis by Origination Year, 2021	127
Term Loans Amortized Cost Basis by Origination Year, Prior	1,389
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	78
Term Loans Amortized Cost Basis by Origination Year, Total	2,447
1-4 family residential mortgages [Member] | Substandard [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, 2021	55
Term Loans Amortized Cost Basis by Origination Year, 2020	507
Term Loans Amortized Cost Basis by Origination Year, 2019	99
Term Loans Amortized Cost Basis by Origination Year, Prior	2,161
Term Loans Amortized Cost Basis by Origination Year, Total	2,822
Commercial Mortgages [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, 2023	48,300
Term Loans Amortized Cost Basis by Origination Year, 2022	40,929
Term Loans Amortized Cost Basis by Origination Year, 2021	50,664
Term Loans Amortized Cost Basis by Origination Year, 2020	108,664
Term Loans Amortized Cost Basis by Origination Year, 2019	44,180
Term Loans Amortized Cost Basis by Origination Year, Prior	191,388
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	2,518
Term Loans Amortized Cost Basis by Origination Year, Total	486,643
Commercial Mortgages [Member] | Pass [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, 2023	48,144
Term Loans Amortized Cost Basis by Origination Year, 2022	40,929
Term Loans Amortized Cost Basis by Origination Year, 2021	48,145
Term Loans Amortized Cost Basis by Origination Year, 2020	105,357
Term Loans Amortized Cost Basis by Origination Year, 2019	36,869
Term Loans Amortized Cost Basis by Origination Year, Prior	168,088
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	2,518
Term Loans Amortized Cost Basis by Origination Year, Total	450,050
Commercial Mortgages [Member] | Watch [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, 2021	265
Term Loans Amortized Cost Basis by Origination Year, 2020	178
Term Loans Amortized Cost Basis by Origination Year, 2019	7,311
Term Loans Amortized Cost Basis by Origination Year, Prior	13,216
Term Loans Amortized Cost Basis by Origination Year, Total	20,970
Commercial Mortgages [Member] | Special Mention [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, 2021	394
Term Loans Amortized Cost Basis by Origination Year, 2020	291
Term Loans Amortized Cost Basis by Origination Year, Prior	4,257
Term Loans Amortized Cost Basis by Origination Year, Total	4,942
Commercial Mortgages [Member] | Substandard [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, 2023	156
Term Loans Amortized Cost Basis by Origination Year, 2021	1,860
Term Loans Amortized Cost Basis by Origination Year, 2020	2,838
Term Loans Amortized Cost Basis by Origination Year, Prior	5,827
Term Loans Amortized Cost Basis by Origination Year, Total	10,681
Consumer [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, 2023	76
Term Loans Amortized Cost Basis by Origination Year, 2022	237
Term Loans Amortized Cost Basis by Origination Year, 2021	590
Term Loans Amortized Cost Basis by Origination Year, 2020	427
Term Loans Amortized Cost Basis by Origination Year, 2019	199
Term Loans Amortized Cost Basis by Origination Year, Prior	25,310
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	14,390
Term Loans Amortized Cost Basis by Origination Year, Loans Converted to Term	9
Term Loans Amortized Cost Basis by Origination Year, Total	41,238
Consumer [Member] | Pass [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, 2023	76
Term Loans Amortized Cost Basis by Origination Year, 2022	237
Term Loans Amortized Cost Basis by Origination Year, 2021	587
Term Loans Amortized Cost Basis by Origination Year, 2020	412
Term Loans Amortized Cost Basis by Origination Year, 2019	179
Term Loans Amortized Cost Basis by Origination Year, Prior	24,303
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	14,389
Term Loans Amortized Cost Basis by Origination Year, Total	40,183
Consumer [Member] | Watch [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, 2020	15
Term Loans Amortized Cost Basis by Origination Year, 2019	12
Term Loans Amortized Cost Basis by Origination Year, Prior	825
Term Loans Amortized Cost Basis by Origination Year, Total	852
Consumer [Member] | Special Mention [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, Prior	75
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	1
Term Loans Amortized Cost Basis by Origination Year, Loans Converted to Term	9
Term Loans Amortized Cost Basis by Origination Year, Total	85
Consumer [Member] | Substandard [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Term Loans Amortized Cost Basis by Origination Year, 2021	3
Term Loans Amortized Cost Basis by Origination Year, 2019	8
Term Loans Amortized Cost Basis by Origination Year, Prior	107
Term Loans Amortized Cost Basis by Origination Year, Total	$ 118

Allowance for Credit Losses (Lo

Allowance for Credit Losses (Loan Portfolio Designated by the Internal Risk Ratings Assigned to Each Credit) (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Financing Receivable, Credit Quality Indicator [Line Items]
Loans	$ 973,348	$ 936,415
Commercial [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans	98,312	71,139
Term Loans Amortized Cost Basis by Origination Year, 2023	28,457
Term Loans Amortized Cost Basis by Origination Year, 2022	12,935
Term Loans Amortized Cost Basis by Origination Year, 2021	3,112
Term Loans Amortized Cost Basis by Origination Year, 2020	5,999
Term Loans Amortized Cost Basis by Origination Year, 2019	9,026
Term Loans Amortized Cost Basis by Origination Year, Prior	15,366
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	22,916
Term Loans Amortized Cost Basis by Origination Year, Total	98,312
Real Estate Construction and Land [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans	29,825	37,541
Term Loans Amortized Cost Basis by Origination Year, 2023	3,665
Term Loans Amortized Cost Basis by Origination Year, 2022	13,539
Term Loans Amortized Cost Basis by Origination Year, 2021	4,512
Term Loans Amortized Cost Basis by Origination Year, 2020	1,754
Term Loans Amortized Cost Basis by Origination Year, 2019	1,304
Term Loans Amortized Cost Basis by Origination Year, Prior	5,051
Term Loans Amortized Cost Basis by Origination Year, Total	29,825
1-4 family residential mortgages [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans	317,330	323,185
Term Loans Amortized Cost Basis by Origination Year, 2023	9,025
Term Loans Amortized Cost Basis by Origination Year, 2022	17,243
Term Loans Amortized Cost Basis by Origination Year, 2021	58,232
Term Loans Amortized Cost Basis by Origination Year, 2020	79,793
Term Loans Amortized Cost Basis by Origination Year, 2019	25,909
Term Loans Amortized Cost Basis by Origination Year, Prior	102,768
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	23,973
Term Loans Amortized Cost Basis by Origination Year, Total	317,330
Commercial mortgages [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans	486,643	459,125
Term Loans Amortized Cost Basis by Origination Year, 2023	48,300
Term Loans Amortized Cost Basis by Origination Year, 2022	40,929
Term Loans Amortized Cost Basis by Origination Year, 2021	50,664
Term Loans Amortized Cost Basis by Origination Year, 2020	108,664
Term Loans Amortized Cost Basis by Origination Year, 2019	44,180
Term Loans Amortized Cost Basis by Origination Year, Prior	191,388
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	2,518
Term Loans Amortized Cost Basis by Origination Year, Total	486,643
Consumer [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans	41,238	45,425
Term Loans Amortized Cost Basis by Origination Year, 2023	76
Term Loans Amortized Cost Basis by Origination Year, 2022	237
Term Loans Amortized Cost Basis by Origination Year, 2021	590
Term Loans Amortized Cost Basis by Origination Year, 2020	427
Term Loans Amortized Cost Basis by Origination Year, 2019	199
Term Loans Amortized Cost Basis by Origination Year, Prior	25,310
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	14,390
Term Loans Amortized Cost Basis by Origination Year, Total	41,238
Excellent [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		30,582
Excellent [Member] | Commercial [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		30,121
Excellent [Member] | Consumer [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		461
Good [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		33,602
Good [Member] | Commercial [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		16,058
Good [Member] | Consumer [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		17,544
Pass [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		800,991
Pass [Member] | Commercial [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		22,853
Term Loans Amortized Cost Basis by Origination Year, 2023	28,457
Term Loans Amortized Cost Basis by Origination Year, 2022	12,818
Term Loans Amortized Cost Basis by Origination Year, 2021	3,101
Term Loans Amortized Cost Basis by Origination Year, 2020	5,959
Term Loans Amortized Cost Basis by Origination Year, 2019	8,560
Term Loans Amortized Cost Basis by Origination Year, Prior	15,005
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	22,694
Term Loans Amortized Cost Basis by Origination Year, Total	96,608
Pass [Member] | Real Estate Construction and Land [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		35,258
Term Loans Amortized Cost Basis by Origination Year, 2023	3,665
Term Loans Amortized Cost Basis by Origination Year, 2022	13,539
Term Loans Amortized Cost Basis by Origination Year, 2021	4,512
Term Loans Amortized Cost Basis by Origination Year, 2020	1,754
Term Loans Amortized Cost Basis by Origination Year, 2019	940
Term Loans Amortized Cost Basis by Origination Year, Prior	2,932
Term Loans Amortized Cost Basis by Origination Year, Total	27,342
Pass [Member] | 1-4 family residential mortgages [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		308,041
Term Loans Amortized Cost Basis by Origination Year, 2023	9,025
Term Loans Amortized Cost Basis by Origination Year, 2022	14,994
Term Loans Amortized Cost Basis by Origination Year, 2021	57,925
Term Loans Amortized Cost Basis by Origination Year, 2020	77,837
Term Loans Amortized Cost Basis by Origination Year, 2019	25,810
Term Loans Amortized Cost Basis by Origination Year, Prior	93,193
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	23,425
Term Loans Amortized Cost Basis by Origination Year, Total	302,596
Pass [Member] | Commercial mortgages [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		408,513
Term Loans Amortized Cost Basis by Origination Year, 2023	48,144
Term Loans Amortized Cost Basis by Origination Year, 2022	40,929
Term Loans Amortized Cost Basis by Origination Year, 2021	48,145
Term Loans Amortized Cost Basis by Origination Year, 2020	105,357
Term Loans Amortized Cost Basis by Origination Year, 2019	36,869
Term Loans Amortized Cost Basis by Origination Year, Prior	168,088
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	2,518
Term Loans Amortized Cost Basis by Origination Year, Total	450,050
Pass [Member] | Consumer [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		26,326
Term Loans Amortized Cost Basis by Origination Year, 2023	76
Term Loans Amortized Cost Basis by Origination Year, 2022	237
Term Loans Amortized Cost Basis by Origination Year, 2021	587
Term Loans Amortized Cost Basis by Origination Year, 2020	412
Term Loans Amortized Cost Basis by Origination Year, 2019	179
Term Loans Amortized Cost Basis by Origination Year, Prior	24,303
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	14,389
Term Loans Amortized Cost Basis by Origination Year, Total	40,183
Watch [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		45,074
Watch [Member] | Commercial [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		992
Term Loans Amortized Cost Basis by Origination Year, 2022	44
Term Loans Amortized Cost Basis by Origination Year, 2019	122
Term Loans Amortized Cost Basis by Origination Year, Prior	7
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	7
Term Loans Amortized Cost Basis by Origination Year, Total	180
Watch [Member] | Real Estate Construction and Land [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		342
Term Loans Amortized Cost Basis by Origination Year, Prior	329
Term Loans Amortized Cost Basis by Origination Year, Total	329
Watch [Member] | 1-4 family residential mortgages [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		7,935
Term Loans Amortized Cost Basis by Origination Year, 2022	1,396
Term Loans Amortized Cost Basis by Origination Year, 2021	125
Term Loans Amortized Cost Basis by Origination Year, 2020	1,449
Term Loans Amortized Cost Basis by Origination Year, Prior	6,025
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	470
Term Loans Amortized Cost Basis by Origination Year, Total	9,465
Watch [Member] | Commercial mortgages [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		34,828
Term Loans Amortized Cost Basis by Origination Year, 2021	265
Term Loans Amortized Cost Basis by Origination Year, 2020	178
Term Loans Amortized Cost Basis by Origination Year, 2019	7,311
Term Loans Amortized Cost Basis by Origination Year, Prior	13,216
Term Loans Amortized Cost Basis by Origination Year, Total	20,970
Watch [Member] | Consumer [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		977
Term Loans Amortized Cost Basis by Origination Year, 2020	15
Term Loans Amortized Cost Basis by Origination Year, 2019	12
Term Loans Amortized Cost Basis by Origination Year, Prior	825
Term Loans Amortized Cost Basis by Origination Year, Total	852
Special Mention [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		9,979
Special Mention [Member] | Commercial [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		122
Term Loans Amortized Cost Basis by Origination Year, 2021	1
Term Loans Amortized Cost Basis by Origination Year, Prior	93
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	215
Term Loans Amortized Cost Basis by Origination Year, Total	309
Special Mention [Member] | Real Estate Construction and Land [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		532
Term Loans Amortized Cost Basis by Origination Year, Prior	750
Term Loans Amortized Cost Basis by Origination Year, Total	750
Special Mention [Member] | 1-4 family residential mortgages [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		5,431
Term Loans Amortized Cost Basis by Origination Year, 2022	853
Term Loans Amortized Cost Basis by Origination Year, 2021	127
Term Loans Amortized Cost Basis by Origination Year, Prior	1,389
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	78
Term Loans Amortized Cost Basis by Origination Year, Total	2,447
Special Mention [Member] | Commercial mortgages [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		3,872
Term Loans Amortized Cost Basis by Origination Year, 2021	394
Term Loans Amortized Cost Basis by Origination Year, 2020	291
Term Loans Amortized Cost Basis by Origination Year, Prior	4,257
Term Loans Amortized Cost Basis by Origination Year, Total	4,942
Special Mention [Member] | Consumer [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		22
Term Loans Amortized Cost Basis by Origination Year, Prior	75
Term Loans Amortized Cost Basis by Origination Year, Revolving Loans	1
Term Loans Amortized Cost Basis by Origination Year, Total	85
Substandard [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		16,187
Substandard [Member] | Commercial [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		993
Term Loans Amortized Cost Basis by Origination Year, 2022	73
Term Loans Amortized Cost Basis by Origination Year, 2021	10
Term Loans Amortized Cost Basis by Origination Year, 2020	40
Term Loans Amortized Cost Basis by Origination Year, 2019	344
Term Loans Amortized Cost Basis by Origination Year, Prior	261
Term Loans Amortized Cost Basis by Origination Year, Total	1,215
Substandard [Member] | Real Estate Construction and Land [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		1,409
Term Loans Amortized Cost Basis by Origination Year, 2019	364
Term Loans Amortized Cost Basis by Origination Year, Prior	1,040
Term Loans Amortized Cost Basis by Origination Year, Total	1,404
Substandard [Member] | 1-4 family residential mortgages [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		1,778
Term Loans Amortized Cost Basis by Origination Year, 2021	55
Term Loans Amortized Cost Basis by Origination Year, 2020	507
Term Loans Amortized Cost Basis by Origination Year, 2019	99
Term Loans Amortized Cost Basis by Origination Year, Prior	2,161
Term Loans Amortized Cost Basis by Origination Year, Total	2,822
Substandard [Member] | Commercial mortgages [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		11,912
Term Loans Amortized Cost Basis by Origination Year, 2023	156
Term Loans Amortized Cost Basis by Origination Year, 2021	1,860
Term Loans Amortized Cost Basis by Origination Year, 2020	2,838
Term Loans Amortized Cost Basis by Origination Year, Prior	5,827
Term Loans Amortized Cost Basis by Origination Year, Total	10,681
Substandard [Member] | Consumer [Member]
Financing Receivable, Credit Quality Indicator [Line Items]
Loans		$ 95
Term Loans Amortized Cost Basis by Origination Year, 2021	3
Term Loans Amortized Cost Basis by Origination Year, 2019	8
Term Loans Amortized Cost Basis by Origination Year, Prior	107
Term Loans Amortized Cost Basis by Origination Year, Total	$ 118

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Goodwill [Line Items]
Goodwill	$ 7,768	$ 8,100	$ 7,768	$ 8,100	$ 7,768	[1]
Change in goodwill					372
Other intangible assets	5,800	7,600	5,800	7,600	$ 6,600
Amortization of intangible assets	$ 379	$ 444	$ 770	$ 900
[1] Derived from audited Consolidated Financial Statements

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets - Schedule of Gross Carrying Amounts and Accumulated Amortization of Other Intangible Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022
Schedule Of Finite And Indefinite Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 9,660	$ 9,660	$ 10,433
Accumulated Amortization	(3,845)	(3,074)	(2,788)
Core Deposit [Member]
Schedule Of Finite And Indefinite Lived Intangible Assets [Line Items]
Gross Carrying Amount	9,660	9,660	9,660
Accumulated Amortization	$ (3,845)	$ (3,074)	(2,255)
Customer Relationships Intangible [Member]
Schedule Of Finite And Indefinite Lived Intangible Assets [Line Items]
Gross Carrying Amount			773
Accumulated Amortization			$ (533)

Goodwill and Other Intangible_5

Goodwill and Other Intangible Assets - Schedule of Estimated Future Amortization Expense (Details) - Core Deposit Intangible [Member] $ in Thousands	Jun. 30, 2023 USD ($)
Schedule of Estimated Future Amortization Expense [Line Items]
For the six months ending December 31, 2023	$ 722
For the year ending December 31, 2024	1,301
For the year ending December 31, 2025	1,110
For the year ending December 31, 2026	918
For the year ending December 31, 2027	726
Thereafter	1,038
Finite-Lived Intangible Assets, Net, Total	$ 5,815

Leases (Narrative) (Details)

Leases (Narrative) (Details)	6 Months Ended
	Jun. 30, 2023
Leases [Abstract]
Lessee, operating lease, existence of option to extend	true
Lease term	12 months

Leases (Schedule of Lease Liabi

Leases (Schedule of Lease Liability, Right-of-use Asset, Weighted Average Remaining Lease Term and Discount Rate) (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022	[1]	Jun. 30, 2022
Leases [Abstract]
Lease liability	$ 6,301			$ 6,925
Right-of-use asset	$ 6,634	$ 6,536		$ 7,343
Weighted average remaining lease term	5 years 10 days			5 years 10 months 2 days
Weighted average discount rate	2.07%			1.97%
[1] Derived from audited Consolidated Financial Statements

Leases (Schedule of Operating L

Leases (Schedule of Operating Lease Expense) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Leases [Abstract]
Operating lease expense	$ 395	$ 449	$ 906	$ 894
Short-term lease expense	81	139	204	191
Total lease expense	476	588	1,110	1,085
Cash paid for amounts included in lease liabilities	$ 336	$ 418	$ 848	$ 832

Leases (Schedule of Operating_2

Leases (Schedule of Operating Lease Liabilities and Reconciliation of Undiscounted Cash Flows) (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Six months ending December 31, 2023	$ 694
Twelve months ending December 31, 2024	1,332
Twelve months ending December 31, 2025	1,248
Twelve months ending December 31, 2026	907
Twelve months ending December 31, 2027	811
Thereafter	1,665
Total undiscounted cash flows	6,657
Less: Discount	(356)
Lease liability	$ 6,301	$ 6,925

Net Income Per Share (Schedule

Net Income Per Share (Schedule of Weighted Average Number of Shares) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022
Basic net income per share
Net Income	$ 5,651	$ 5,791	$ 5,685	$ 4,924	$ 11,442	$ 10,609
Basic, Weighted Average Shares	5,357,873		5,326,271		5,348,040	5,319,166
Basic, Per Share Amount	$ 1.05		$ 1.07		$ 2.14	$ 1.99
Effect of dilutive stock options, Weighted Average Shares	17,200		20,737		27,505	26,076
Effect of dilutive stock options, Per Share Amount			$ (0.01)		$ (0.01)	$ (0.01)
Diluted net income per share
Net Income	$ 5,651	$ 5,791	$ 5,685	$ 4,924	$ 11,442	$ 10,609
Diluted, Weighted Average Shares	5,375,073		5,347,008		5,375,545	5,345,242
Diluted, Per Share Amount	$ 1.05		$ 1.06		$ 2.13	$ 1.98

Net Income Per Share (Narrative

Net Income Per Share (Narrative) (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Equity Option [Member]
Earnings Per Share [Line Items]
Securities considered to be anti-dilutive and excluded from earnings per share calculation	105,501	101,901	105,501	101,901

Stock Incentive Plans (Plan dur

Stock Incentive Plans (Plan duration - Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended			6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Jun. 23, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock grant expense				$ 231	$ 214
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 68		$ 41	110	$ 83
Unrecognized compensation expense related to the non-vested awards	$ 153			$ 153
Unrecognized compensation expense related to the non-vested awards, final year of recognition				2026
Option Issued	3,600	0	0	3,600	0
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense related to the non-vested awards	$ 1,900			$ 1,900
Unrecognized compensation expense related to the non-vested awards, final year of recognition				2027
Stock grants awarded		0	0	27,332
Stock grant expense	$ 120			$ 231
Restricted Stock [Member] | Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock grants awarded				8,400	5,580
Restricted Stock [Member] | Non Employee Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock grants awarded				18,932	12,856
Restricted Stock [Member] | Employee And Non Employee Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period				4 years
Unrestricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock grants awarded				0
Unrestricted Stock [Member] | Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock grants awarded					100
Unrestricted stock grant expense					$ 3
Minimum [Member] | Restricted Stock [Member] | Employee And Non Employee Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period					4 years
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Plan duration				10 years
Maximum [Member] | Restricted Stock [Member] | Employee And Non Employee Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period					5 years
2022 Stock Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock authorized for issuance	150,000			150,000		150,000
Common stock available for grant	131,068			131,068
Percentage of common stock authorized for issuance				95%
2014 Stock Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock authorized for issuance	275,625			275,625		275,625
Common stock available for grant	6,031			6,031
2005 Stock Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock authorized for issuance	253,575			253,575
Common stock available for grant	0			0		0

Stock Incentive Plans (Summary

Stock Incentive Plans (Summary of Shares Issued and Available Under Each Plans) (Details) - $ / shares	6 Months Ended
	Jun. 30, 2023	Jun. 23, 2022
2022 Stock Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate shares issuable	150,000	150,000
Remaining available for grant	131,068
Total vested and unvested shares	18,932
2022 Stock Plan [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock grants issued	(18,932)
2014 Stock Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate shares issuable	275,625	275,625
Options issued, net of forfeited and expired options	(173,706)
Remaining available for grant	6,031
Total vested and unvested shares	95,888
Fully vested shares	48,675
2014 Stock Plan [Member] | Unrestricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock grants issued	(11,635)
2014 Stock Plan [Member] | Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock grants issued	(84,253)
2014 Stock Plan [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total vested and unvested shares	170,501
Fully vested shares	109,616
2014 Stock Plan [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range	$ 23.75
2014 Stock Plan [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range	$ 42.62
2005 Stock Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate shares issuable	253,575
Options issued, net of forfeited and expired options	(59,870)
Cancelled due to Plan expiration	(193,705)
Remaining available for grant	0	0

Stock Incentive Plans (Changes

Stock Incentive Plans (Changes in the Stock Options Outstanding) (Details) - Employee Stock Option [Member] - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended			6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Number of Options
Outstanding, at the beginning		168,280		168,280
Issued	3,600	0	0	3,600	0
Exercised				(1,379)
Outstanding, at the end	170,501			170,501
Options Exercisable	109,616			109,616
Weighted Average Exercise Price
Outstanding, at the beginning		$ 33.95		$ 33.95
Issued				35.13
Exercised				(13.69)
Outstanding, at the end	$ 34.14			34.14
Exercisable	$ 36.72			$ 36.72
Aggregate Intrinsic Value
Outstanding, Aggregate Intrinsic Value	$ 488			$ 488		$ 830
Exercisable	$ 222			$ 222

Stock Incentive Plans (Summar_2

Stock Incentive Plans (Summary Information Pertaining to Options Outstanding) (Details)	6 Months Ended
	Jun. 30, 2023 $ / shares shares
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Options Outstanding | shares	170,501
Weighted-Average Remaining Contractual Life	6 years 4 months 24 days
Weighted Average Exercise Price	$ 34.14
Options Exercisable | shares	109,616
Weighted-Average Exercise Price	$ 36.72
$23.75 to $30.00 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price, Minimum	23.75
Exercise Price, Maximum	$ 30
Options Outstanding | shares	65,000
Weighted-Average Remaining Contractual Life	7 years
Weighted Average Exercise Price	$ 24.65
Options Exercisable | shares	30,600
Weighted-Average Exercise Price	$ 24.9
$30.01 to $40.00 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price, Minimum	30.01
Exercise Price, Maximum	$ 40
Options Outstanding | shares	48,020
Weighted-Average Remaining Contractual Life	7 years 3 months 18 days
Weighted Average Exercise Price	$ 36.83
Options Exercisable | shares	21,536
Weighted-Average Exercise Price	$ 37.79
$40.01 to $42.62 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price, Minimum	40.01
Exercise Price, Maximum	$ 42.62
Options Outstanding | shares	57,481
Weighted-Average Remaining Contractual Life	4 years 10 months 24 days
Weighted Average Exercise Price	$ 42.62
Options Exercisable | shares	57,480
Weighted-Average Exercise Price	$ 42.62

Stock Incentive Plans (Change_2

Stock Incentive Plans (Changes in the Restricted Stock Grants Outstanding) (Details) - Restricted Stock [Member] - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2023	Jun. 30, 2022	Jun. 30, 2023
Number of Shares/Options
Non-vested Outstanding, at the beginning	51,664		51,664
Issued	0	0	27,332
Vested			(12,851)
Forfeited			0
Non-vested Outstanding, at the end			66,145
Weighted Average Grant Date Fair Value Per Share/Exercise Price
Non-vested Outstanding, at the beginning	$ 32.05		$ 32.05
Issued			32.73
Vested			30.4
Forfeited			0
Non-vested Outstanding, at the end			$ 32.65
Aggregate Intrinsic Value
Non-vested Outstanding, at the beginning	$ 1,661		$ 1,661
Issued			879
Vested			(413)
Forfeited			0
Non-vested Outstanding, Aggregate Intrinsic Value			$ 2,127

Fair Value Measurements (Assets

Fair Value Measurements (Assets Measured at Fair Value on Recurring Basis) (Details) - Fair Value, Recurring [Member] - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities measured at fair value		$ 538,692
Total securities available for sale	$ 473,868	538,186
Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities measured at fair value		538,692
Total securities available for sale	473,868	538,186
U.S. Government Treasuries [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total securities available for sale	175,551	242,470
U.S. Government Treasuries [Member] | Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total securities available for sale	175,551	242,470
U.S. Government Agencies [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total securities available for sale	38,839	28,755
U.S. Government Agencies [Member] | Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total securities available for sale	38,839	28,755
Mortgage-backed Securities/CMOs [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total securities available for sale	157,788	167,076
Mortgage-backed Securities/CMOs [Member] | Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total securities available for sale	157,788	167,076
Corporate Bonds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total securities available for sale	18,702	18,729
Corporate Bonds [Member] | Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total securities available for sale	18,702	18,729
Municipal Bonds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total securities available for sale	82,988	81,156
Municipal Bonds [Member] | Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total securities available for sale	$ 82,988	81,156
Interest Rate Swap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities measured at fair value		506
Interest Rate Swap [Member] | Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities measured at fair value		$ 506

Fair Value Measurements (Narrat

Fair Value Measurements (Narrative) (Details) - Fair Value, Nonrecurring [Member] $ in Thousands	Dec. 31, 2022 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets measured at fair value	$ 0
Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets measured at fair value	$ 0

Fair Value Measurements - Asset

Fair Value Measurements - Assets Measured at Fair Value on a Nonrecurring Basis (Details) - Fair Value, Nonrecurring [Member] - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets measured at fair value		$ 0
Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets measured at fair value		$ 0
Individually Evaluated Loans [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets measured at fair value	$ 461
Individually Evaluated Loans [Member] | Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets measured at fair value	$ 461

Fair Value Measurements - Quant

Fair Value Measurements - Quantitative Information About Level 3 Fair Value Measurements (Details) - Market Comparables [Member] - Individually Evaluated Loans [Member] - Fair Value, Nonrecurring [Member] - Significant Unobservable Inputs (Level 3) [Member] $ in Thousands	6 Months Ended
	Jun. 30, 2023 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value	$ 461
Unobservable Inputs	Discount applied to recent appraisal
Discount Rate	20

Fair Value Measurements (Carryi

Fair Value Measurements (Carrying Values and Estimated Fair Values of Financial Instruments) (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Assets
Restricted securities	$ 7,438	$ 5,137	[1]
Fair Value, Nonrecurring [Member] | Carrying Value [Member]
Assets
Cash and cash equivalent	29,939	40,136
Available for sale securities	473,868	538,186
Restricted securities	7,438	5,137
Loans, net	965,485	930,863
Assets held for sale		965
Bank owned life insurance	39,065	38,552
Accrued interest receivable	5,092	4,879
Interest rate swap asset		506
Liabilities
Demand deposits and interest-bearing transaction, money market, and savings accounts	1,123,120	1,363,232
Certificates of deposit	224,956	115,106
Federal funds purchased	20,503
FHLB Borrowings	59,666
Junior subordinated debt, net	3,436	3,413
Accrued interest payable	1,059	157
Fair Value, Nonrecurring [Member] | Fair Value [Member]
Assets
Cash and cash equivalent	29,939	40,136
Available for sale securities	473,868	538,186
Restricted securities	7,438	5,137
Loans, net	902,429	890,929
Assets held for sale		965
Bank owned life insurance	39,065	38,552
Accrued interest receivable	5,092	4,879
Interest rate swap asset		506
Liabilities
Demand deposits and interest-bearing transaction, money market, and savings accounts	1,123,120	1,363,232
Certificates of deposit	224,677	109,260
Federal funds purchased	20,503
FHLB Borrowings	59,717
Junior subordinated debt, net	3,436	3,413
Accrued interest payable	1,059	157
Fair Value, Nonrecurring [Member] | Fair Value [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Assets
Cash and cash equivalent	29,939	40,136
Fair Value, Nonrecurring [Member] | Fair Value [Member] | Significant Other Observable Inputs (Level 2) [Member]
Assets
Available for sale securities	473,868	538,186
Restricted securities	7,438	5,137
Assets held for sale		965
Bank owned life insurance	39,065	38,552
Accrued interest receivable	2,137	2,265
Interest rate swap asset		506
Liabilities
Demand deposits and interest-bearing transaction, money market, and savings accounts	1,123,120	1,363,232
Certificates of deposit	224,677	109,260
Federal funds purchased	20,503
FHLB Borrowings	59,717
Junior subordinated debt, net	3,436	3,413
Accrued interest payable	1,059	157
Fair Value, Nonrecurring [Member] | Fair Value [Member] | Significant Unobservable Inputs (Level 3) [Member]
Assets
Loans, net	902,429	890,929
Accrued interest receivable	$ 2,955	$ 2,614
[1] Derived from audited Consolidated Financial Statements

Other Comprehensive Income - Sc

Other Comprehensive Income - Schedule of Component of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023		Jun. 30, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss), Beginning Balance			$ (48,624)	[1]	$ (2,211)
Other comprehensive income (loss) arising during the period			3,601		(44,916)
Related income tax effects			(757)		9,432
Total other comprehensive loss before reclassification			2,844
Total other comprehensive income (loss)	$ (3,127)	$ (16,054)	2,644		(35,484)
Reclassification into net income			(254)
Related income tax effects			54
Reclassification into net income net of tax			(200)
Accumulated other comprehensive income (loss), Ending Balance	(45,980)	(37,695)	(45,980)		(37,695)
Interest Rate Swap [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss), Beginning Balance			400		(47)
Other comprehensive income (loss) arising during the period			(46)		499
Related income tax effects			9		(104)
Total other comprehensive loss before reclassification			(37)
Total other comprehensive income (loss)					395
Reclassification into net income			(460)
Related income tax effects			97
Reclassification into net income net of tax			(363)
Accumulated other comprehensive income (loss), Ending Balance		348			348
AFS Securities [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive income (loss), Beginning Balance			(49,024)		(2,164)
Other comprehensive income (loss) arising during the period			3,647		(45,415)
Related income tax effects			(766)		9,536
Total other comprehensive loss before reclassification			2,881
Total other comprehensive income (loss)					(35,879)
Reclassification into net income			206
Related income tax effects			(43)
Reclassification into net income net of tax			163
Accumulated other comprehensive income (loss), Ending Balance	$ (45,980)	$ (38,043)	$ (45,980)		$ (38,043)
[1] Derived from audited Consolidated Financial Statements

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities (Narrative) (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Gain on termination of interest swap	$ 479
Cash collateral held at other banks		$ 580

Derivative Instruments and He_2

Derivative Instruments and Hedging Activities - (Summary of Derivative Instruments) (Details) - Derivatives Designated as Hedging Instruments [Member] - Junior Subordinated Debt [Member] - Interest Rate Forward Swap - Cash Flow [Member] $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($)
Derivative [Line Items]
Notional/contract amount	$ 4,000
Fair value	$ 506
Expiration Date	Jun. 15, 2031

Segment Reporting (Narrative) (

Segment Reporting (Narrative) (Details)	6 Months Ended
	Jun. 30, 2023 Item
Segment Reporting Information [Line Items]
Number of reportable segments	4

Segment Reporting (Schedule of

Segment Reporting (Schedule of Segment Reporting Information) (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022
Segment Reporting Information [Line Items]
Net interest income	$ 13,703		$ 12,461		$ 27,116	$ 23,886
Provision for (recovery of) credit losses	261		(217)		13	(69)
Noninterest income	2,045		3,646		4,321	8,433
Noninterest expense	8,564		9,442		17,425	19,537
Income before income taxes	6,923		6,882		13,999	12,851
Provision for (benefit from) income taxes	1,272		1,197		2,557	2,242
Net income	5,651	$ 5,791	5,685	$ 4,924	11,442	10,609
Bank [Member]
Segment Reporting Information [Line Items]
Net interest income	13,703		12,461		27,116	23,886
Provision for (recovery of) credit losses	261		(217)		13	(69)
Noninterest income	1,637		2,851		3,492	4,385
Noninterest expense	7,987		8,717		16,355	17,538
Income before income taxes	7,092		6,812		14,240	10,802
Provision for (benefit from) income taxes	1,308		1,181		2,607	1,811
Net income	5,784		5,631		11,633	8,991
Sturman Wealth Advisors [Member]
Segment Reporting Information [Line Items]
Noninterest income			210			426
Noninterest expense			161			327
Income before income taxes			49			99
Provision for (benefit from) income taxes			11			21
Net income			38			78
VNB Trust & Estate Services [Member]
Segment Reporting Information [Line Items]
Noninterest income	250		365		510	3,196
Noninterest expense	361		376		672	1,298
Income before income taxes	(111)		(11)		(162)	1,898
Provision for (benefit from) income taxes	(24)		(2)		(34)	399
Net income	(87)		(9)		(128)	1,499
Masonry Capital [Member]
Segment Reporting Information [Line Items]
Noninterest income	158		220		319	426
Noninterest expense	216		188		398	374
Income before income taxes	(58)		32		(79)	52
Provision for (benefit from) income taxes	(12)		7		(16)	11
Net income	$ (46)		$ 25		$ (63)	$ 41